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Chapter 1: Net return distributions across antimicrobials used for
metaphylaxis to control bovine respiratory disease in high health
risk cattle
Net return losses due to cattle mortality and morbidity associated with bovine respiratory
disease (BRD) has a substantial impact on the feedlot industry. Metaphylaxis is a common
feedlot cattle health management practice used to limit cattle morbidity and mortality at-
tributed to BRD. Efficacy of antimicrobials used for metaphylaxis is known to vary by cattle
population. How this differing antimicrobial efficacy translates to net return profitability
for heterogeneous cattle populations is less understood. The objective of this article is to
measure the net return profitability and uncertainty of Upper Tier and Lower Tier antimicro-
bials used for metaphylaxis. Using information from 10 feedlots representing a half-million
animals and 1500 cohorts between 1989-2015 we find the expected value of administering an
Upper Tier (Lower Tier) metaphylaxis treatment compared to no treatment for high health
risk steers is $90.46/head ($28.06) for 600 lb. and $118.85/head ($41.74) for 800 lb. winter
placements. Furthermore, the probability or risk of net return losses worsening by at least
$50/head is significantly reduced (from approximately 15% to 4%) when any metaphylaxis
antimicrobial is used on high health risk cattle. The expected value and net return risk
mitigated by metaphylaxis use on high health risk cattle varies by placement weight, season,
and antimicrobial used.
Chapter 2: Value of Arrival Metaphylaxis in U.S. Cattle Industry
Dennis, Elliott J., Ted C. Schroeder, David G. Renter, and Dustin L. Pendell. 2018.
“Value of Arrival Metaphylaxis in US Cattle Industry.” Journal of Agricultural and
Resource Economics 43(2):233-249.
Although several studies have estimated economic impacts of antimicrobials for growth pro-
motion, little is known about economic impacts of the common animal health management
strategy known as metaphylaxis: administering antimicrobials to groups of animals to pre-
vent disease. This article develops a new framework to map animal disease to producer
profitability and determine societal economic impacts surrounding metaphylactic use of an-
timicrobials in beef cattle production. Results indicate the direct net return value of meta-
phylaxis to the U.S. fed cattle industry is at least $532 million. Beef producer surplus losses
of $1.8 billion would be associated with eliminating metaphylaxis.
Chapter 3: Why do livestock producers use metaphylaxis? Self-
insurance vs. self-protection and an market insurance alternative
Antimicrobial resistance in humans is increasing and there is growing concern that antimicro-
bials used in livestock production is contributing to this growth. Metaphylaxis, administering
FDA approved injectable antimicrobials to high health risk livestock upon arrival at feeding
operations, is one animal health strategy producers use to reduce the size or magnitude of
livestock morbidity and mortality. International organizations have explicitly aimed to re-
move metaphylaxis for disease prevention but there is concern that few, if any, alternative
health management strategies exist. Likewise, little is known about under what conditions
livestock producers use metaphylaxis and if they would be willing to substitute away if a
feasible market alternative were available. This article develops a theoretical framework for
why metaphylaxis is used in US cattle feedlots. Our results indicate that when no market
insurance is available, feedlots use more income for disease prevention than disease treat-
ment. However, producers equalize disease treatment and prevention expenditures when an
actuarially fair market insurance is available. We develop a simple elementary market insur-
ance product that could be used and show that feedlots can improve their wealth position
over metaphylaxis when a market insurance product is used.
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Abstract
Chapter 1: Net return distributions across antimicrobials used for
metaphylaxis to control bovine respiratory disease in high health
risk cattle
Net return losses due to cattle mortality and morbidity associated with bovine respiratory
disease (BRD) has a substantial impact on the feedlot industry. Metaphylaxis is a common
feedlot cattle health management practice used to limit cattle morbidity and mortality at-
tributed to BRD. Efficacy of antimicrobials used for metaphylaxis is known to vary by cattle
population. How this differing antimicrobial efficacy translates to net return profitability
for heterogeneous cattle populations is less understood. The objective of this article is to
measure the net return profitability and uncertainty of Upper Tier and Lower Tier antimicro-
bials used for metaphylaxis. Using information from 10 feedlots representing a half-million
animals and 1500 cohorts between 1989-2015 we find the expected value of administering an
Upper Tier (Lower Tier) metaphylaxis treatment compared to no treatment for high health
risk steers is $90.46/head ($28.06) for 600 lb. and $118.85/head ($41.74) for 800 lb. winter
placements. Furthermore, the probability or risk of net return losses worsening by at least
$50/head is significantly reduced (from approximately 15% to 4%) when any metaphylaxis
antimicrobial is used on high health risk cattle. The expected value and net return risk
mitigated by metaphylaxis use on high health risk cattle varies by placement weight, season,
and antimicrobial used.
Chapter 2: Value of Arrival Metaphylaxis in U.S. Cattle Industry
Dennis, Elliott J., Ted C. Schroeder, David G. Renter, and Dustin L. Pendell. 2018.
“Value of Arrival Metaphylaxis in US Cattle Industry.” Journal of Agricultural and
Resource Economics 43(2):233-249.
Although several studies have estimated economic impacts of antimicrobials for growth pro-
motion, little is known about economic impacts of the common animal health management
strategy known as metaphylaxis: administering antimicrobials to groups of animals to pre-
vent disease. This article develops a new framework to map animal disease to producer
profitability and determine societal economic impacts surrounding metaphylactic use of an-
timicrobials in beef cattle production. Results indicate the direct net return value of meta-
phylaxis to the U.S. fed cattle industry is at least $532 million. Beef producer surplus losses
of $1.8 billion would be associated with eliminating metaphylaxis.
Chapter 3: Why do livestock producers use metaphylaxis? Self-
insurance vs. self-protection and an market insurance alternative
Antimicrobial resistance in humans is increasing and there is growing concern that antimicro-
bials used in livestock production is contributing to this growth. Metaphylaxis, administering
FDA approved injectable antimicrobials to high health risk livestock upon arrival at feeding
operations, is one animal health strategy producers use to reduce the size or magnitude of
livestock morbidity and mortality. International organizations have explicitly aimed to re-
move metaphylaxis for disease prevention but there is concern that few, if any, alternative
health management strategies exist. Likewise, little is known about under what conditions
livestock producers use metaphylaxis and if they would be willing to substitute away if a
feasible market alternative were available. This article develops a theoretical framework for
why metaphylaxis is used in US cattle feedlots. Our results indicate that when no market
insurance is available, feedlots use more income for disease prevention than disease treat-
ment. However, producers equalize disease treatment and prevention expenditures when an
actuarially fair market insurance is available. We develop a simple elementary market insur-
ance product that could be used and show that feedlots can improve their wealth position
over metaphylaxis when a market insurance product is used.
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Net return distributions across tiers of
antimicrobials used for metaphylaxis
to control bovine respiratory disease
in high health risk cattle
1.1 Introduction
Antimicrobials used to improve wellbeing, health, and performance of cattle arriving at
feedlots, has received considerable public attention. Metaphylaxis, administration of an an-
timicrobial, generally via injection, is used selectively by 59% of U.S. feedlots on 20.5% of
cattle to reduce adverse effects of bovine respiratory disease (BRD) (United States Depart-
ment of Agriculture, 2013). Randomized control trials have generally confirmed metaphylaxis
can reduce morbidity and mortality in feedlot cattle having high health risk susceptibility
(O’Connor et al., 2013; Abell et al., 2017).
When cohorts of cattle arrive at feedlots, producers assess animal health risk and decide
whether to employ metaphylaxis. Perceived benefits of metaphylactic treatment to reduce
cattle morbidity and mortality are weighed against costs to process, treat, and monitor
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cattle. If metaphylaxis treatment is utilized, producers must select the type of antimicrobial
to administer (Nickell and White, 2010). Selection of the specific antimicrobial to use is
based on veterinary consultation, past experience, and duration of action (United States
Department of Agriculture, 2013).
While the efficacy and cost of antimicrobials for metaphylaxis varies, how different an-
timicrobials used for metaphylaxis translates into expected net return distributions for het-
erogeneous cattle is even less well understood (DeDonder and Apley, 2015; Ives and Richeson,
2015). Realized cattle morbidity and mortality conditional on antimicrobial choice and ad-
ministration is unknown until after cattle harvest. As such, animal health outcomes are
stochastic when a metaphylaxis treatment decision is made.
The objective of this article is to measure expected net return and associated uncer-
tainty of two antimicrobial classes used for metaphylaxis. In particular, we test whether
expected net return distributions vary across cattle placement weight, placement season,
and antimicrobial administered using data obtained from a panel of 10 Midwestern feed-
lots. Observational panel data enables us to calibrate net return simulations using observed
outcomes. Results contribute to better understanding how alternative metaphylactic antimi-
crobial options influence expected cattle feeding returns and return risk.
1.2 Materials and Methods
Cattle feeding net returns vary across management, marketing, and animal health protocols.
Cattle feeding net return distributions are estimated using a stochastic simulation model
developed by Dennis et al. (2018). We modify their model by specifically incorporating cattle
and antimicrobial heterogeneity into the simulation.1 Stochastic2 net return simulations have
1The primary purpose of Dennis et al. (2018) was to estimate economic value of metaphylaxis for the
U.S. fed cattle industry and determine if removing metaphylaxis as an animal health protocol would shift
aggregate U.S. beef supply. They accomplished this by assuming an average sex, placement season, and
antimicrobial used for metaphylaxis. We modify their simulation method to incorporate heterogeneity into
cattle populations and antimicrobials used for metaphylaxis.
2Stochastic simulations are distinctly different than deterministic simulations because they incorporate
uncertainty via probability distributions obtained from historical data, expert opinion, and/or published
literature.
2
been used to value BRD for dairy, cow-calf, and feedlot cattle (Van der Fels-Klerx et al.,
2001; Buhman et al., 2003; Nor et al., 2012; Theurer et al., 2015; Wang et al., 2018) and to
value metaphylaxis in feedlot cattle (Dennis et al., 2018). In what follows, we briefly describe
the cattle feeding economic decision framework used in our simulation emphasizing how we
modify the Dennis et al. (2018) cattle feeding net return simulation model.
1.2.1 Cattle Feeding Net Return Simulation
We consider four types of high health risk steers purchased by producers - two different
cattle placement weights (600 or 800 lbs.) and two placement seasons (Oct-Mar (referred to
as winter) or Apr-Sept (referred to as summer)). Producers manage high health risk steers by
either using or not using metaphylaxis. In our simulation, we consider two different classes
of antimicrobials used for metaphylaxis (Upper Tier or Lower Tier3). Thus, we consider 8
different metaphylaxis scenarios in our simulation (two placement weights, two seasons, and
two antimicrobials for metaphylaxis) and we compare these to 4 no metaphylaxis scenarios
for each placement weight - season combination.
Regardless of initial health status and health management strategy, cattle can become
sick and/or die. Producers realize final morbidity and mortality only at cattle harvest. All
cattle, regardless of initial health risk status, possessing clinical signs of BRD are pulled and
treated. Sick cattle incur greater health costs (HC ↑), gain less weight per day during feeding
(ADG ↓), and require more feed to gain an additional lb of weight. (AFC ↑).4 Producers
do not sell dead animals (CSW=0) losing the initial cost of the feeder (FDRC) plus costs
of yardage (YC), feed (FC), interest (IC), and health treatments (HC). Since final cattle
mortality is unknown at purchase, producers effectively face a random draw from a mortality
distribution conditional on cattle placement weight, season, and possible antimicrobial used
for metaphylaxis. While both morbidity and mortality combine to increase total feeding costs
(TC ↑) and decreases total revenue (TR ↓), mortality poses the highest cost to producers
3Upper tier and lower tier antimicrobials are taken from Abell et al. (2017) where they classify antimi-
crobials conditional on OR confidence intervals.
4Increasing feed conversion implies that it requires more feed to obtain one pound of gain. Thus, as
morbidity increases some feed conversion increases.
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and is the primary driver of net return variation in the simulation.
After initial processing, cattle that survive and reach an expected harvest weight are
sold on a live-weight basis. Thus, cattle feeders choose the type of cattle to purchase, initial
and supplemental health treatments, and target weight of finished cattle. Given this, cattle











×{ CSW︸ ︷︷ ︸
Finished weight
× (1− SHRINK)︸ ︷︷ ︸
Transportation weight loss
× (1−MORT− CULL︸ ︷︷ ︸
Proportion of animlas sold
}
︸ ︷︷ ︸
Lbs. of animals sold
+ (CULL× CULLW× CULLP)︸ ︷︷ ︸
Revenue from culled animals
(1.2)
FDRC︸ ︷︷ ︸
Cost to purchase cattle
= FRP︸︷︷︸
Feeder price
















×[CSW× (1−MORT− CULL)− CPW]︸ ︷︷ ︸
Total weight gain while at feedlot
}
︸ ︷︷ ︸




= {0.5× [YC + FC + HC] + FDRC︸ ︷︷ ︸
Entire feeder and half of all other costs
} × DOF︸ ︷︷ ︸
Days on feed
× (IR/365)︸ ︷︷ ︸
Interest rate
(1.6)
Table A.1 in appendix A describes each variable in detail.
Our objective is to determine how net return distributions change for high health risk
cattle as metaphylaxis treatment protocol varies for different placement weights and seasons.
To do this, we calibrate the expected return in the simulation models by using breakeven (π
= 0) feeder cattle purchase prices for the Upper Tier antimicrobial used for each season and
placement weight. This enables us to compare net return distributions with and without
metaphylaxis within season and placement weight.
4
Cattle Morbidity and Mortality
Metaphylaxis is expected to reduce morbidity and mortality in high health risk feedlot cat-
tle, but expected efficacy varies by cattle placement weight, placement season, gender, and
antimicrobial used (Nickell and White, 2010; DeDonder and Apley, 2015; Ives and Richeson,
2015). Historical morbidity in observational data are generally not available. Cattle produc-
tivity measures serve as proxies for morbidity. Multivariate Tobit, ordinary least squares,
maximum likelihood, and linear mixed models have been used to model variation in average
daily gain, veterinary/medication costs, and feed conversion in cattle across different sea-
sons, placement weights, etc. (Miller et al., 2005; Irsik et al., 2006; Belasco, 2008; Belasco
et al., 2009; Dennis et al., 2018). We use a linear mixed model to account for the hierarchical
nature of cattle feeding data where cohorts of cattle are nested within feedlots. This allows
us to capture cohort level animal management practices that can differ across feedlots.
Cattle mortality is conditional on cattle health-risk category, cattle placement weight,
and placement season. Metaphylaxis modifies cattle mortality risk. Mortality distributions
are right-skewed with long tails, approximated using a log-normal, (zero inflated) negative
binomial or a (zero-inflated) Poisson distribution (Babcock, 2010). We model mortality
distributions as log-normal conditional on placement risk category, weight, and season.
Mortality distributions of high health risk cattle managed with metaphylaxis are observed
in feedlot data. However, mortality of high health risk cattle not managed with metaphy-
laxis are not observed in feedlot data because feedlots treat all cattle categorized as high
health risk upon arrival. Thus, mortality distributions for high health risk cattle not treated
with metaphylaxis were approximated using odd-ratios from a mixed treatment comparison
(MTC) meta-analysis (Abell et al., 2017). The MTC meta-analysis summarizes published
randomized control antimicrobial trials for BRD related cattle morbidity from day 1 to close-
out and assesses indirect comparisons across different antimicrobials used for metaphylaxis
(O’Connor et al., 2013; Abell et al., 2017).
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1.3 Data
Ten large commercial feedlot operations located in several Midwestern states provided two
animal health and performance data sets used in this study. Cohorts are the common aggre-
gate unit in commercial feedlot production systems. Cohort-level animal health treatment
information is the primary difference between the two data sets. We define cohorts (lots or
pens) as animals purchased, assembled, and managed as an observable unit. When finished
cattle are marketed, closeouts record cohort-level animal performance and health informa-
tion.
Observational data used in this study includes a large panel data set comprising 48,341
cohorts of cattle (about 6 million head) placed on feed during 1989-2008. This data set con-
sists of typical closeout information including health costs after feeding has begun excluding
costs of metaphylaxis. These data are used to calibrate animal feeding performance over
time (i.e., ADG and AFC) which varies by season, location, and animal weight. The second
observational data used in this study comprises 1,203 cohorts of cattle (about 264,000 head)
placed on feed during 2014-2015. This more comprehensive, but smaller data set, documents
both lot and individual animal antimicrobial treatments associated with BRD enabling us
to estimate cost of metaphylaxis and facilitates our stochastic simulation around death loss.
1.4 Results
1.4.1 Descriptive Statistics
Cattle performance parameters across the two observational data sets were compared to
assess whether the cattle had similar feeding characteristics (feed conversion, daily gain,
mortality, placement weight, and days on feed). Table ?? displays summary statistics for
the feedlot data. T-tests for each animal feeding attribute indicate cattle from both periods
were not statistically different from each other with the exception of more steers placed in the
second period. On average [min, max] cattle were placed at approximately 700 lb., gained 3
lb. per day [1.5, 6.0], and had feed conversion of about 6 [3.0, 9.9] over 155 days on feed [128,
6
229]. Cattle were placed evenly across seasons. Average death loss for period one cattle was
1.24% [0.0, 25.6]. Large variation in death loss is due to initial health status, differing cattle
populations, and other factors. Large death losses are associated with cohorts classified as
high risk and managed with metaphylaxis.
1.4.2 Estimated Morbidity
Cattle morbidity is not directly observed in our feedlot data but manifests itself in lower
average daily gain (ADG ↓), increased average feed conversion (AFC ↑), and increased health
costs (HC ↑). The impact of cattle mortality is quantified using a linear mixed model (LMM)
with pen- and feedlot-specific fixed and random effects. Specifically, we estimate ADG and
AFC using the large panel data set and associated health costs (HC) using the more intensive
recent data set. Table ?? displays parameter estimates for the estimated models. ADG and
AFC are estimated as a function of the percentage of cohort level mortality (MORT), the
natural log of cattle placement weight (lnPWT), whether the cohort were steers (STEER),
and whether cattle were placed between October and March (WINTER). Cohort level health
costs (HC) are estimated in similar format to ADG and AFC but WINTER is omitted
because of the short time horizon of the data and binary variables indicating the class of
antimicrobial given for metaphylaxis are included (UPPER TIER or LOWER TIER).
Mortality reduces daily gains (ADG ↓) and increases feed conversion (AFC ↑) and health
costs (HC ↑). Higher placement weights are associated with lower daily gains (ADG ↓),
higher feed conversions (AFC ↑), and lower health costs (HC ↓) consistent with randomized
control trials that indicate lighter weight animals are more susceptible to harmful bacteria
(Nickell and White 2010). Steers gain more weight per day on feed and convert feed more
efficiently. Cattle placed during winter months are associated with lower cattle performance
consistent with literature demonstrating cattle devote more energy to body temperature
maintenance during colder months (Mader et al., 2010).
UPPER TIER and LOWER TIER are binary variables indicating the class of antimi-
crobial used for metaphylaxis. If an Upper Tier (Lower Tier) antimicrobial is used for
7
metaphylaxis, a producer incurs an estimated $30.55 ($25.65)/head cost for administration.
These findings are consistent with results from the National Animal Health Monitoring Sur-
vey (NAHMS, U.S. Department of Agriculture, 2013) that reported costs of $23.50/head to
administer metaphylaxis to feeder cattle. Our values are slightly higher since it includes all
health cost treatments during the time on feed and not just the cost of the initial cost of
metaphylaxis upon arrival.
1.4.3 Mortality Distributions
One important concern is the endogenous choice by the producer to match the type of meta-
phylaxis to cattle populations. For example, producers may wish to administer a different
drug to similar types of cattle based the perceived or observed morbidity and mortality. This
decision is not observed in the data and cannot be proxied by variables in our data. Thus
traditional assumption of matching on observable is not possible since even after matching
cattle are likely to be different.5
We multiply the odd ratio by a hypothetical no metaphyalxis death loss to obtain a
proposed metaphylaxis death loss. We then iterate through different no metaphylaxis death
losses until the proposed metaphylaxis death loss matches the metaphylaxis death loss ob-
served in the proprietary data. This obtained no metaphylaxis death loss can be used to
obtain the metaphylaxis that would have been observed in the upper tier metaphylaxis. The
upper tier metaphylaxis death loss is obtained by multiplying the odd ratio for the upper tier
metaphylaxis by the death loss of no metaphylaxis. This method allows for the death loss
distributions, and subsequent net return distributions, to be compared. One can interpret
the derived upper tier metaphylaxis as the death loss the would had been observed had the
upper tier metaphylaxis been given in place of the lower tier metaphylaxis. 6
Log-normal distributions are fit using the mean and standard deviation of death for
5The intuition behind this is relatively straightforward. Given that cattle are similar in every respect and
a profit maximizing producer, the low metaphylaxis drug would be chosen. Thus, even after matching it is
not random chance that certain cattle populations are given a certain metaphylaxis.
6The ratio of these death losses represent the relative performance of one metaphylaxis drug to the other.
Based on our proposed method, the upper tier metaphylaxis is almost 4 times more effective than the lower
tier metaphylaxis. This finding is consistent with the odd ratios found by Abell et al. (2017).
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the different tiers of metaphylaxis and no metaphylaxis. Figure 1.1 displays log-normal
mortality distributions for high health risk steers conditional on placement weight, season,
and antimicrobial used for metaphylaxis.
Four types of high risk steers are considered in our simulation - two different placement
weights (600 or 800 lbs.) and two placement seasons (winter or summer). Each cattle
type has three alternative animal health management practices (do-nothing, Upper Tier
antimicrobial, or Lower Tier antimicrobial).
Both antimicrobials used for metaphylaxis reduce expected death loss and associated
variance. Larger death loss is associated with steers placed during winter months at lighter
weights. Upper Tier antimicrobials on average reduce mortality by more than Lower Tier
antimicrobials. Larger variation in death loss is present across all seasons and placement
weights for high health risk steers not managed with metaphylaxis. Thus, metaphylaxis
reduces mortality in high health risk steers but varies by class of antimicrobial used.
1.4.4 Net Return Distributions
Figure 1.2 displays net return distributions by cattle placement weight and season across
the three alternative animal health treatment protocols. The simulated net returns were
generated by randomly selecting mortality from the distributions in Figure 1.1, using the
estimated equations reported in Table ??, and calculating net returns using equation 1. This
process was repeated with replacement 5,000 times to generate the distributions. No meta-
phylaxis net return distributions in Figure 1.2 represent high health risk steer cohorts not
managed with metaphylaxis upon arrival. The differences in expected net returns per head
(averages) between administering an Upper Tier (Lower Tier) to high risk steers compared
with not administering metaphylaxis are: 1) $64.97 ($16.52) for 600 lb. summer placements;
2) $58.47 ($13.73) for 600 lb. winter placements; 3) $90.46 ($28.06) for 800 lb. summer
placements; and 4) $118.85 ($41.74) for 800 lb. winter placements. The difference between
the Upper Tier and Lower Tier is the marginal net value benefit of using a certain tier of
antimicrobial. For example, the value of administering an Upper Tier compared to a Lower
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Tier for 600 lb. summer placements is $48.45 (58.47-13.73=48.45). On average, Upper
Tier antimicrobials are valued at $58.17 compared to Lower Tier antimicrobials across all
placement weights and seasons.
Both antimicrobials used for metaphylaxis increase expected net returns and decrease
return variance. Thus, cattle producers are more certain that they will realize greater profit
on a high-risk pen of cattle when metaphylaxis is used. Table 1.3 further summarizes the net
return distributions displayed in Figure 1.2 reporting percentages of cohorts falling within
expected net return ranges conditional on cattle placement weight, placement season, and
antimicrobial used. Metaphylaxis administered to high health risk cattle substantially re-
duces the probability of large losses. For example, for a 600 lb. summer placed high risk
steers treated with a Upper Tier, there is an 0.02% (0.00% + 0.02%) chance of realizing a
loss of more than $50 per head, whereas if these high risk steers were not treated, they would
face a 27% (4.62% + 22.42%) chance of losing more than $50 per head. For a 600 lb. winter
placed high risk pen treated with a Lower Tier there would be a 21% (1.82% + 19.46%)
chance of realizing at least a $50 per head loss contrasted to not treating this high risk pen
with a 31% (8.02% + 23.50%) probability of realizing at least a $50 per head loss. Taking
this result further, large losses in excess of $250 per head have a 15% (4% to 24%) proba-
bility of being realized for high risk 600 lb. placements not treated with any antimicrobial
compared to generally less than 5% (0% to 19%) probability of such large losses regardless
of season or antimicrobial administered for metaphylaxis treatment.
An interesting result relative to the decision to treat high risk pens with metaphylaxis
is that high returns (low death losses) can still, by chance, be realized whether the animals
are or are not treated with metaphylaxis. For example, for 600 lb. high risk steers placed,
regardless of season or antimicrobial, if they were administered metaphylaxis we would expect
more than 43% of the time to realize net returns of at least $51 per head. However, there is
still at least a 23% chance the high risk pen would realize $51 per head or more even if not
treated with metaphylaxis. This is because there is always a chance high risk cattle, even if
not treated, will remain sufficiently healthy and not suffer substantial mortality.
Heavier weight placements are less likely to have large negative returns since the pro-
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portion of cattle that die is relatively small compared to lighter placements. For example,
a 600 lb. summer placed high risk pen administered a Upper Tier would face a 0% (0.00%
+ 0.00%) chance of realizing a loss greater than $51 per head compared to 25% (0.80% +
23.94%) for an 800 lb. placement at the same time administered the same metaphylaxis
treatment. Summer placed high risk cattle are expected to have similar risks of large losses
compared to winter placements. For example, 800 lb. summer placed high risk cattle treated
with Lower Tier have an 11% (0.00% + 11.36%) probability of realizing a loss of more than
$50 per head compared to a winter placement of the same animals of 25% (0.80% + 23.94%).
1.5 Discussion
The decision of whether to treat high risk cattle with metaphylaxis, and if so, which class
of antimicrobial to use is a difficult question to answer in part because the decisions are
made with incomplete information. Realized health outcomes are only known after cattle
are finished feeding whereas metaphylaxis health treatment decisions are generally made at
cattle placement. Thus, we must rely on expected return distributions with and without use
of metaphylaxis to assess economic viability.
Expected return alone is not sufficient to assess viability of metaphylaxis if return risk
also matters. Treating all high risk cattle with metaphylaxis broadly increases expected
net return and reduces return uncertainly. This makes the use of metaphylaxis as a health
management practice appear obvious. However, the change in expected return as well as
the risk mitigated through metaphylactic treatment of all high risk cattle varies by season
of placement, type of antimicrobial employed, and cattle placement weight. Lighter-weight
high risk cattle are expected to realize greater returns and more return risk mitigation
through metaphylaxis regardless of season and drug type (of those investigated here), than
heavier-weight placements.
The value of meeting contracting agreements is a value of metaphylaxis not currently
captured. Feedlots can use metaphylaxis as a preventative measure to ensure a correct
number of healthy cattle reach harvest weight to comply with marketing agreements and
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contracts. Given this the value of metaphylaxis represents more than just the loss in input
costs as currently calculated. Thus, estimated values likely serve as a lower bound to the
value of metaphylaxis.
An important issue, not addressed in this study but clearly based on the results deserves
much more consideration, is how to identify and categorize high risk cattle. High risk cattle
are worth less to the feedlot since they require higher health costs and have greater morbidity
and mortality risk. However, often high health risk cattle not treated with metaphylaxis do
not realize major net return losses - instead they perform fine in the feedlot. Whether this
is from mis-categorization or randomness in animal health outcomes remains unclear. But,
we expect with more accurate categorization of cattle into health risk status upon feedlot
arrival, health management strategies could be refined. Of course, the cost of acquiring
additional information for more accurate animal health status classification may exceed the
value.
Fed and feeder cattle price levels impact the value of metaphylaxis for each antimicrobial.
The average fed cattle price used in this simulation was $148/cwt (see Table A.1). Higher
fed cattle prices create greater value associated with metaphylaxis, ceteris paribus; as cattle
prices increase, the cost of animal death loss increases. As such, fed cattle price has important
impacts on the value of metaphylaxis because higher fed cattle prices, ceteris paribus, are
associated with higher feeder cattle prices and any death loss has a greater economic cost.
1.6 Conclusion
Net return simulation results identified the value of two classes of antimicrobial commonly
used for metaphylaxis. The antimicrobials are valued more than not administering antimi-
crobials but varies by cattle season, placement weight, and gender. Further research is needed
to determine the values for specific antimicrobials used for metaphylaxis.
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1.7 Tables
Table 1.1: Feedlot Performance Summary Characteristics
January 1989-December 2008a Mean Std. Dev. Min Max.
Feed conversion (lb. feed/lb. gain) 6.07 0.59 3.01 9.91
Average daily gain (lb. gain/day) 2.96 0.56 1.51 5.98
Mortality (%) 1.24 1.76 0.00 25.64
Placement weight (lb.) 683.7 128.99 304.20 1,100.00
Days on feed (days) 154.5 44.17 128.00 229.00
Gender Steer 46.0% Heifer 54.0%
Season
Spring 25.1% Summer 27.4%
Fall 24.3% Winter 23.2%
August 2014-December 2015b Mean Std. Dev. Min Max.
Feed conversion (lb. feed/lb. gain) 6.14 0.58 4.29 8.76
Average daily gain (lb. gain/day) 3.24 0.49 1.65 5.18
Mortality (%) 2.54 3.19 0.00 26.78
Placement weight (lb.) 700.8 177.49 301.00 1096.00
Days on feed (days) 192.8 67.20 87.00 443.30
Gender Steer 55.0% Heifer 45.0%
Season
Spring 25.8% Summer 23.2%
Fall 25.8% Winter 25.2%
a Period one has 48,341 cohorts/pens
b Period two has 1,203 cohorts/pens
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Table 1.2: Linear Mixed Model (LMM) Estimation for Cattle Performance which serves as
a Proxy for Cattle Morbidity
ADG AFC HC
Fixed Effects
Constant -4.536 (0.10)a -1.129 (0.14) 13.371 (1.97)
Mortality (MORT) -0.059 (0.00) 0.050 (0.00) 1.399 (0.08)
Log Placement Weight (LnPWT) 1.147 (0.01) 1.144 (0.02) 0.004 (0.00)
Steer (STEER) 0.238 (0.00) -0.272 (0.01) 1.294 (0.41)
Oct-Mar (WINTER) 0.009 (0.00) 0.004 (0.01)
Antimicrobial (Upper Tier) 29.565 (0.80)
Antimicrobial (Lower Tier) 24.750 (0.81)
Random Effectsb
Company 0.016 0.016 14.4178
Pen Size 0.002 0.003 0.5008
Placement Year 0.007 0.072
Observations 48,341 48,341 1,203
REML Convergence 41,637.68 75,791.04 7,998.1
a Numbers in parenthesis () are standard errors






























































































































































































































































































































































































































































Figure 1.1: Death Loss Distributions for High Health Risk Steers by Placement Weight,
Placement Season, and Type of Antimicrobial used for Metaphylaxis
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Figure 1.2: Net Return Distributions for High Health Risk Steers by Placement Weight,
Placement Season, and Type of Antimicrobial used for Metaphylaxis
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Chapter 2
Value of Arrival Metaphylaxis in U.S.
Cattle Industry
2.1 Introduction
Public concern over use of shared-class antimicrobials in animal feeding operations, an-
timicrobial resistant bacteria, and potential antimicrobial residuals in meat has escalated in
recent years.1 Major restaurants, food service companies, food processors, and supermarkets
have pledged to reduce or eliminate antimicrobial use in meat production (Pew Charitable
Trusts, 2016). Federal and international organizations have expressed growing concerns that
the use of shared-class antimicrobials in livestock production for growth promotion2 and
disease prevention is linked to increased health risks and antimicrobial resistance in humans
(Centers for Disease Control and Prevention, 2013; World Health Organization, 2012).
Metaphylaxis is an animal health management practice that administers FDA-approved
antimicrobials, generally via injection, to groups of high-risk animals in order to eliminate or
minimize acute onset of a disease (United States Department of Agriculture, 2013). Cattle
1Antimicrobials are classified by their production use. Shared-class antimicrobials are medically important
to both human and animal health.
2“Production purposes” refers to products that are used with the intent to enhance growth or improve
feed efficiency rather than treat disease. Growth-promotion antimicrobials are commonly referred to as
“sub-therapeutic.”
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producers selectively use this tool to reduce beef cattle health risks when cattle first arrive
at feeding facilities and occasionally during feeding. While scientific evidence linking meta-
phylaxis use in animal production to negative impacts on human health is sparse, select
countries and international organizations have strongly recommended an overall reduction
in the use of shared-class antimicrobials for disease prevention without individual animal
diagnosis (World Health Organization, 2015, 2017). Current debate centers on whether
to include further regulate metaphylaxis in the United States. Since metaphylaxis reduces
bovine respiratory disease (O’Connor et al., 2013; Abell et al., 2017), the most common cause
of morbidity and mortality in beef cattle, livestock producers are concerned that removing
such a widely used production technology would be detrimental to animal health and result
in substantial animal deaths, reduced animal welfare, increased production risk, and reduced
profitability (Fears, 2015).
This paper estimates the value of metaphylactic use in U.S. cattle feeding and determine
implications for consumer and producer surplus of eliminating its use. First, we develop a fed
cattle industry simulation model to estimate net returns under alternative market conditions,
policies, and animal production technologies. Second, using 20 years of proprietary data
from 10 large commercial Midwestern feedlots, we obtain short-run estimates of the effect of
banning the use of metaphylaxis upon recently arrived cattle. Third, these results are used
to estimate changes in producer and consumer surplus at major market levels to determine
economic impacts of eliminating metaphylaxis.
Several studies have estimated the economic impacts of banning antimicrobials in live-
stock production used in feed and water (Hayes et al., 2001; Brorsen et al., 2002; Miller et al.,
2005; MacDonald and Wang, 2011; Key and McBride, 2014). In contrast, little economic
research has evaluated metaphylactic antimicrobial use in animal production. Antimicrobial
use in feed and water and the health management practice of metaphylaxis have distinct
purposes, uses, animal outcomes, and producer profitability. Antimicrobials administered
in feed and water balance beneficial and harmful bacteria to improve nutrition and cre-
ate homogeneous animal populations (Cromwell, 2002). Antimicrobials administered during
metaphylactic treatment strive to reduce clinical and subclinical morbidity and mortality
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caused by actual or prospective illness. While both are production technologies used to
manage animal health, antimicrobials in feed and water are often used to increase animal
efficiency, whereas metaphylaxis specifically treats groups of animals with elevated health
risk. This important distinction requires a new framework to map animal disease and health
treatment strategies to producer profitability and estimate societal economic impacts sur-
rounding metaphylactic use in beef cattle production.
In what follows, we first describe alternative health management practices in United
States feedlots with primary focus on metaphylaxis. Next, we incorporate metaphylaxis
into a feedlot producer decision framework accounting for how metaphylaxis modifies animal
health and subsequently producer profitability. Main findings and how sensitive these results
are to model calibration are presented in the next section. We conclude with how the cost
of removing of metaphylaxis as a health management practice in beef feedlots is passed both
within and between different meat markets.
2.2 Background
Metaphylactic intervention reduces mortality and morbidity risk, may reduce medication
costs, reduces days on feed, and can improve carcass and offal quality (Schumann et al.,
1990, 1991; Van Donkersgoed, 1992; Duff et al., 2000; Encinias et al., 2006; Cernicchiaro
et al., 2012; Tennant et al., 2014). Metaphylaxis is used to reduce the risk or impacts of
an outbreak of bovine respiratory disease (BRD), the most common cause of morbidity and
mortality in U.S. beef cattle production, affecting 97% of feedlots, 16% of cattle, and costing
the beef industry an estimated $6 billion annually (Griffin, 1997; United States Department
of Agriculture, 2013). Metaphylaxis is selectively used by 59% of U.S. feedlots on 20.5%
of cattle placed on feed across all cattle placement weights (United States Department of
Agriculture, 2013).
The primary alternative health management to metaphylaxis is to only treat clinically ob-
served sick animals, commonly referred to as “pull-and-treat”. Compared to metaphylaxis,
targeted pulling and treating animals is costlier when disease risk is high. Metaphylaxis
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and pull-and-treat are commonly used jointly to manage high-health-risk cattle. However,
as the number of times an animal is pulled and treated increases, medication costs rise,
carcass and offal quality decline, and mortality and culling rates increase (Belasco et al.,
2009; Cernicchiaro et al., 2013). Hence, pull-and-treat is rarely used as the primary ap-
proach for managing high-health-risk cattle, which are often more effectively managed using
metaphylaxis followed by selective pull-and-treat.
Injectable antimicrobials, to which the metaphylaxis protocol is a major contributor,
accounted for 4% of total U.S. antimicrobial sales and distribution for livestock and other
animals (Food and Drug Administration, 2016). Use of antimicrobials in feed and water, to
which the metaphylaxis protocol is a minor contributor, is much more prevalent. Antimi-
crobials in feed and water account for 74% and 22% of total antimicrobial sales, whereas
injectable antimicrobials, to which the metaphylaxis protocol is a major contributor, ac-
counted for 4%. Hence, impact assessments have primarily focused on removing the larger
relative proportion of antimicrobials in feed and water for hogs, broilers, and cattle. Since
metaphylaxis impacts cattle performance parameters and reduces mortality and morbidity
as well, producer and consumer surplus losses are likely more pronounced. To our knowledge,
no prior research has estimated the value of metaphylaxis on the beef cattle sector and its
associated economic surplus impacts on society.
2.3 Data
Proprietary data were collected from 10 large commercial feedlot operations located in Mid-
western states. The datasets encompass two periods: 1989-2008 and 2014-2015. The first
period comprises 48,341 pens of cattle (about 6 million head) over 20 years. Period 2 com-
prises 1,321 pens of cattle (about 264,000 head) over 1.5 years. Data for period 1 are typical
feedlot closeout data and are used to calibrate animal feeding performance (ADG and AFC)
variation conditioned on season, location, and animal weight. Health costs reported exclude
arrival health treatments, capturing only total animal health cost after feeding began; thus,
health costs for this dataset exclude possible costs associated with metaphylaxis. Data for
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period 2 contain similar animal feedlot performance variables for the same companies but,
because of the shorter period, are not well suited for making inferences across time, season,
and location. The data from period 2 detail health costs documenting metaphylaxis use,
individual animal costs associated with BRD, and their impact on cattle performance, none
of which are available in period 1. Specifically, the more recent data enable us to identify
costs associated with metaphylaxis in our cattle feeding risk simulation. Table ?? displays
summary statistics for the feedlot data.
2.4 Methods
2.4.1 Simulation Framework
A cattle feeding simulation model is developed to incorporate how metaphylaxis conditions
cattle morbidity and mortality. Variation in cattle morbidity and mortality influences net
return distributions under alternative health management scenarios for heterogeneous at-risk
fed cattle. Net returns from cattle feeding, sold under a live-weight basis, are translated into
short-run producer and consumer surplus changes with and without the use of metaphylaxis
in treatment of high-health-risk cattle.
Producers first select a vector of cattle characteristics (α) that includes gender, place-
ment weight, and expected harvest weight.3 In the simulation, feedlots purchase cattle at
three different weight categories (ω) where ω = calves (550 lb.), middle-weights (700 lb.),
or yearlings (850 lb.).4 Once cattle are purchased, α is fixed and cattle are categorized as
either low- or high-health-risk.5 Low-health-risk cattle have low production and mortality
3Feedlots make feeder cattle purchase decisions based on feeder cattle supplies, feed costs, and season and
adjust their cattle price offers in accordance with perceived animal health risk. Prospective buyers categorize
cattle into economic risk groups conditional on expected mortality and morbidity risk, cattle performance
and characteristics, feeding location, and time of year. Higher transaction prices are generally associated
with healthier animals with lower probabilities of morbidity and mortality.
4Younger cattle have less-developed immune systems and are more susceptible to infection and disease.
Few cattle purchased in the United States have a verified age. The weight categories selected reflect cattle
purchase weights commonly used by producers.
5Low- and high-health-risk cattle are often simultaneously available for purchase across different weight
classes. Producers mitigate health risk in high-health-risk cattle through health management practices such
as metaphylaxis. Animal health-risk assessment for cattle purchased by feedlots is based on cattle weight and
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risks and are never prescribed metaphylaxis but are individually treated when clinical signs
of morbidity are manifest (i.e., pull-and-treat). High-health-risk cattle are prescribed meta-
phylaxis upon arrival at the feedlot and individually treated for clinical signs of morbidity
and mortality.
Producers, with veterinarian oversight, select a health management strategy (τ) that
maximizes expected animal well-being, performance, and ultimately profit. Given α, ω, and
τ , a producer faces a random cattle death loss (φω,τ ). Death loss distributions for each ω× τ
high-health-risk cattle combination are calibrated using feedlot data and metaphylaxis mul-
tipliers from Abell et al. (2017). Appendix B describes in more detail how these distributions
were generated. Thus, the primary driver of feedlot profitability in our simulator is cattle
mortality (MORT). Mortality distributions are displayed in figure 2.1.
The impact of mortality on cattle performance parameters, γ, is estimated from feedlot
data using linear mixed model (LMM) regressions, which are commonly used in epidemio-
logic studies. Appendix B describes in more detail the estimation and results of said LMMs.
Performance parameters for cattle are measured for aggregate groups of animals that either
live and are marketed as fed cattle at harvest or die during feeding. As mortality rates in-
crease, pen performance parameters become skewed downward, often to irrational values. To
overcome this, net returns are calculated for k = dead, alive broad groups of cattle purchased
by producers: i) animals that survive feeding and sold and ii) animals that die. Given α, the
kth group death loss assumption, and a vector (γk) of expected values, we calculate three
cattle performance parameters (ADG, AFC, and HC) using proprietary feedlot data. ADG
is the average weight (in lb.) gained during the feeding period, AFC is the average amount
of feed (in lb.) consumed for an additional pound of weight gain, and HC is health costs
associated with feeding.
The variables ADG, AFC, and HC are known to be correlated with each other and vary
by risk category and health intervention. To make these variables individually stochastic,
age, whether cattle have been comingled from multiple sources, distance cattle traveled prior to placement,
season, and prior health treatments that may have been administered. In this study, we define high-risk
cattle as those entering the feedlot where metaphylaxis was used as the initial health management practice
(United States Department of Agriculture, 2013)
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yet correlated, we model the joint distribution using Iman and Conover (1980) algorithm
for 10,000 iterations. We assumed cattle performance parameters (ADG, AFC, and HC) are
distributed Nk ∼ (γk, σ), where σ is a vector of variances from the estimated LMM residuals
and γk is the previously specified estimates of ADG, AFC, and HC for the kth group, given
a linear dependency structure. This produces simulated cattle parameters (ADG, AFC, and
HC) with mean, variance, and dependency structure of cattle performance variables identical
to those observed in feedlot data.
We use simulated ADG, AFC, and HC values, random cattle death loss, fixed prices, and
exogenous feedlot characteristics to calculate cattle feeding net returns, ρω,k,τ , defined as
ρω,k,τ = TRω,k,τ − FDRCω − Y Cω,k,τ − FCω,k,τ −HCω,k,τ − ICω,k,τ (2.1)
TRω,k,τ =FP × CSWk × (1− SHRINK)× (1−MORTω,k,τ − CULL)+
(CULL× CULLW × CULLP )
(2.2)
FRDCω = FRPω × CPWω (2.3)
Y Cω,k,τ = 0.30×DOFω,k,τ (2.4)
FCω,k,τ = FEED × [AFCω,k,τ [CSWω,k,τ × (1−MORTω,k,τ − CULL)− CPWω]] (2.5)
ICω,k,τ = [0.5× [Y Cω,k,τ + FCω,k,τ +HCω,τ ] + FRDCω]×DOFω,k,τ × (IR/365) (2.6)
Table 2.2 displays and explains the simulated and fixed feeding net return variables used in
equations 2.1 - 2.6.
A weighted-average net returns of cattle feeding (πω,τ ) is recovered using the matrix of
calculated cattle feeding net returns (ρω,k,τ ) from equations 2.1 - 2.6. Given the stochastic
mortality (φω,τ ) and a representative pen size of 120 head, φω,τ × 120 number of net returns
from the ρω,dead,τ distribution are included while the remaining (1 − φω,τ × 120) cattle net
returns are selected from φω,alive,τ . This is done 10,000 times, taking the mean of each
iteration and thus obtaining a weighted-average net return distribution φω,τ .
A weighted-average net return φω,τ for each weight-by-treatment category, where ω =
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(500,700,850 pound placement weight) and τ = (metaphylaxis, no metaphylaxis) is used to
calculate the industry net return value of metaphylaxis and the value of metaphylaxis as a
proportion of industry gross revenue to high-risk cattle. The latter is calculated as
θ =
∑3
ω=1(vω × cω × xω)
ξ
(2.7)
where the value per head of health management strategy (vω) is obtained by taking the
difference in expected values from the health intervention (i.e., metaphylaxis). The number
of cattle placed on feed in a given year in each weight class is cω, xω is the proportion of
cattle administered metaphylaxis, and ξ is the fed cattle industry total revenue calculated
as pounds produced multiplied by dollars per pound for fed cattle.
2.4.2 Producer and Consumer Surplus Impact
A multimarket partial equilibrium that allows for shocks in the fed cattle industry to be
transmitted from beef to pork, lamb, and poultry is framed using an equilibrium displacement
model (EDM). The EDM is used to estimate changes in producer and consumer surplus that
would be incurred by fully eliminating the use of metaphylaxis in the fed cattle industry.
EDMs have frequently been used in the livestock and meat sector for determining the impacts
of exogenous shocks along and across marketing chains. Lusk and Anderson (2004) and
Brester et al. (2004) used EDMs to estimate the effects of country-of-origin labeling on meat
producers and consumers. Schroeder and Tonsor (2011) constructed an EDM to estimate
economic impacts of removing a cattle feeding production technology. Pendell et al. (2013)
employed an EDM to assess impacts of international trade for requirements of cattle age and
source verification.
The EDM we use in this study is an updated version of the multimarket partial equi-
librium model documented in Pendell et al. (2010). Market parameters-including supply,
demand, and quantity transmission elasticities as defined in Pendell et al. (2010) were re-
tained, with updates to selected elasticity estimates (see online supplement).6 The EDM
6Demand elasticities were updated to reflect more current demand elasticity estimates. The updated
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is composed of four sectors for the beef and lamb industries: retail (consumers), wholesale
(packers), fed (cattle/lamb feeding), and farm (cow-calf/lamb producers). Pork and poultry
markets are highly integrated and thus we model them using three sectors: retail, wholesale,
and producer. Each sector explicitly models international trade at the wholesale sector. The
base year price and quantity were updated to reflect 2015 prices and quantities. Changes
in consumer and producer surplus can be calculated from changes in prices and quantities
from the EDM model. Equation 2.7 represents the one-time, 1-year exogenous shock to the
fed cattle sector of removing metaphylaxis.
2.5 Results
We selected feeder cattle prices to use in the simulation so that comparisons could be made
across treatment groups for each specific placement weight. For example, net returns for 550
lb. feeder cattle can be compared with and without metaphylaxis administered. Figure 2.2
depicts the simulated net returns of metaphylaxis use on high-risk cattle across the three
placement weight categories. Negative values indicate the losses conditioned by metaphylaxis
treatment. All reported results are on a per head live-weight basis for a weighted-average
gender and season.
Overall, using metaphylaxis reduces mean occurrence and extreme death loss, resulting
in greater net returns with reduced variability. Metaphylaxis is most profitable when ad-
ministered to high-risk cattle with lighter placement weight. On average, high-risk 550 lb.
placements lose $104.46/head when not treated with metaphylaxis, high-risk 700 lb. cattle
lose $99.26/head, and high-risk 850 lb. cattle lose $63.36/head relative to treated cattle.
elasticities used in the EDM are retail beef -0.420 (Tonsor et al., 2010), fed cattle -0.66 (Marsh 1992), feeder
cattle -0.62 (Marsh, 1992), retail pork -0.7396 (Tonsor et al., 2010), and retail poultry -0.099 (Tonsor et al.,
2010).
26
2.5.1 Impact of Removing Metaphylaxis
The percentage of cattle administered metaphylaxis and the number of cattle placed on feed
by weight category were used to translate the simulated return distributions into an industry-
wide valuation of metaphylaxis. The Livestock Marketing Information Center (2017) reports
placements of cattle by year and weight category from USDA data. Weight categories compa-
rable to those used in our simulation were obtained by aggregating cattle into three placement
weight groups: 500-625 lb., 626-775 lb., and 776-925 lb.. Roughly one-third of cattle placed
on feed in 2015 were in each calculated category with slightly more placements in heavier
weights.
The NAHMS intermittently monitors and surveys health management practices in the
cattle industry. In 2011, feedlots with more than 1,000-head capacity reported metaphylaxis
administration rates of 2.81%, 18.01%, and 68.01% for 850 lb., 700 lb., and 550 lb. cattle
placed on feed, respectively (United States Department of Agriculture, 2013). Using these
assumptions and equation (10), we calculated the value of metaphylaxis as a percentage of
the U.S. fed cattle industry.
Table 2.3 summarizes the results. Metaphylaxis is worth $532.18 million to the cattle
feeding industry. That is, if metaphylaxis were eliminated in the feedlot sector, not allowing
cattle producers to substitute into other health management or procurement practices, net
returns to the cattle feeding sector would decline by $532.18 million annually, equivalent to
a 0.92% reduction in gross feedlot revenue.
Several important differences were revealed when comparing the percentage of cattle
given metaphylaxis reported by NAHMS in 2011 and proprietary feedlot health data from
10 large commercial Midwestern feedlots analyzed in 2014-2015 (period 2 data). Feedlot
data indicate metaphylaxis health management changes by weight category. Heavier-weight
cattle are administered metaphylaxis less often than lighter cattle. The proprietary feedlot
data indicated that metaphylaxis was administered to 86.85% of 550-625 lb. placements,
23.10% of 626-775 lb. placements, 3.59% of 776-925 lb. placements, and 26.00% of all cat-
tle placed. These estimates are higher than those reported by NAHMS of 68.01%, 18.01%,
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2.81%, and 20.50%, respectively, for each of the three placement weight categories and over-
all cattle treatment. Using the more intense metaphylaxis use from the feedlot data, we
estimated an alternative value of metaphylaxis to the fed cattle industry. If metaphylaxis
were administered in the United States at the same rate as in our feedlot sample, eliminat-
ing metaphylaxis would reduce net returns to the cattle feeding sector by $679.56 million
annually, equivalent to 1.17% of industry gross revenue (see Table 2.3).
Several limitations are important to mention before interpreting the reported estimated
values of metaphylaxis. First, the estimated valuation is likely an upper estimate because
the simulation model does not enable producers to switch to another health management
strategy if metaphylaxis use were eliminated. No substantial alternative presently exists that
could effectively replace metaphylaxis, so how much our estimate overstates the impact is
debatable. However, it provides an estimate for how much an alternative health management
technology could cost and still incentivize producer adoption. Short-term solutions would
likely revolve around changes in cattle procurement strategies by weight and season rather
than switching to other technologies, which would imply that industry losses would be similar
to those estimated here but shifted upstream to feeder cattle suppliers.
Second, the net return simulation depends on calibrating the death-loss distributions,
particularly how they differ with and without metaphylaxis. No large-scale randomized
trial of the impacts of metaphylaxis (versus negative control cattle) exists. Our death loss
distribution is calibrated from a mixed treatment control meta-analysis that examined 29
randomized control studies, which are the most reliable estimates available. In the following
section, we evaluate how sensitive our results are to this calibration.
Third, the percentage of cattle given metaphylaxis in each group affects the total value
of the health management strategy. Larger placements of 550 lb. animals increase the shock
magnitude.
Fourth, fed and feeder cattle price levels impact the value of metaphylaxis. Higher fed
cattle prices create greater value associated with metaphylaxis, ceteris paribus; as cattle
prices increase, the cost of animal death loss increases. How much this affects our estimates
is discussed in the following section.
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Fifth, metaphylaxis is only eliminated from cattle production. This implies pork and
poultry producers would not change antimicrobial use practices. This simplification allows
us to obtain a cattle-specific value of metaphylaxis without other compounding effects.
Sensitivity Analysis
The two important drivers of results in the simulation model are feeder and fed cattle prices
and the death loss distributions of fed cattle. The average fed cattle price used in this
simulation was $148/cwt (see Table 2.2). To illustrate the sensitivity of results to cattle
prices, we compared results with two different fed cattle prices, $171.00/cwt and $125.24/cwt,
which correspond to high and low prices observed between Fall 2011 and Fall 2017. These
represent prices approximately 15% above and below the base simulation price. Results
reveal that, if cattle were prescribed metaphylaxis at the rate specified by NAHMS, the
net return value of metaphylaxis would be $639.83 million (19.11% higher) if the fed cattle
price were $171.00/cwt and $424.71 million (20.19% lower) with $125.24/cwt. As such, fed
cattle price has important impacts on the value of metaphylaxis because higher fed cattle
prices, ceteris paribus, are associated with higher feeder cattle prices and any death loss has
a greater economic cost.
The median odds ratio estimates proposed by Abell et al. (2017) were used to calibrate
the death loss distributions used in the base simulated model. The authors calculated 95%
confidence intervals for two common macrolides, Tilmicosin and Tulathromycin. Using this
information, we estimated death loss calibrations for the 2.5th and 97.5th percentiles. Results
are sensitive to death loss distributions. Given the metaphylaxis application rates reported
by NAHMS, removing metaphylaxis would result in feedlot net return losses of $91.01 million
at the 2.5th percentile and $1,119.56 million at the 97.5th percentile.
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2.5.2 Surplus Implications
We quantify short-run societal impacts of removing metaphylaxis. Column 3 of table 2.3
are used as the shocks to the fed cattle industry.7 Table 2.4 presents surplus estimates of
a complete removal of metaphylaxis using both the NAHMS survey data and proprietary
feedlot data with the associated 0.92% and 1.17% losses in net returns to the cattle feeding
industry. Feedlots ultimately pass costs downstream to feeder cattle producers, resulting in
higher losses in the feeder cattle sector. Feedlots would lose from $924.86 million to $1,179.85
million, and feeder cattle producers would lose $1,060.78 million to $1,354.22 million in
producer surplus in year 1 if metaphylaxis were eliminated. Higher beef retail prices induce
consumers to substitute into other meat products, leading to gains for pork, poultry, and
lamb producers.
The wholesale beef market would lose $206.97 million to $267.45 million, while retailers
would experience a short-run surplus gain of $377.45 million to $476.70 million. Overall, beef
producer surplus would decline by $1,809.52 million to $2,322.44 million. Total consumer
surplus would decrease by $1,074.23 million to $1,370.51 million.
2.6 Conclusion
Antimicrobial use in livestock production is an increasingly important societal concern. All
animal drug use is regulated, and we will continue to see more stringent regulationsthe VFD
and state-mandated antibiotic-use policies are recent examples. In addition, consumers
and retailers are becoming more health conscious, demanding more traceability, restrictive
farming practices, and no antibiotic use in meat production. These demands and policies
will continue to increase costs while offering minimal demand responses, thus reducing both
consumer and producer welfare (Saitone et al., 2015).
On the policy horizon is whether metaphylaxis, an integral animal health management
strategy administered to high health risk cattle upon arrival at feeding operations, should
7For example, if metaphylaxis is valued at 5% of industry value then removing metaphylaxis would result
in a loss of 5% of industry value. Thus, the shock would be -0.05
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be more intensively regulated or even eliminated as an animal health management option.
To our knowledge, this study is the first to estimate the value of metaphylaxis, an animal
health treatment, in any livestock sector, with particular focus on the U.S. beef cattle sector.
Metaphylaxis is uniquely suited to reduce mortality and morbidity in high-health-risk
animals. Using industry metaphylaxis data from the National Animal Health Monitoring
System surveys and proprietary feedlot production data, the net return value of metaphy-
laxis to the cattle feeding industry is $532 million to $680 million per year. Eliminating
metaphylaxis would reduce beef producer surplus by $1.81 billion to $2.32 billion and overall
consumer surplus by $1.15 billion to $1.47 billion per year.
Removing a production technology (such as metaphylaxis) that directly impacts animal
mortality risk is costlier than removing a production technology (such as antimicrobials in
feed and water) that targets production efficiency. Producer and consumer surplus estimates
are larger in comparison to studies that estimated short-run economic impacts of bans on
antimicrobials in feed and water ($280.55 million for beef producers (Mathews, 2002), $45.36
million to $291.24 million for pork producers (Wade and Barkley, 1992; Brorsen et al., 2002;
Sneeringer et al., 2017), and $189.00 million for poultry producers (Sneeringer et al., 2017)).
The better we can predict animal health, quantify uncertainty, and determine net re-
turn distributional impacts for antimicrobial use practices in cattle production, the more
informed specific policy options become. Results also inform industry stakeholders about
how much production/marketing practices would need to be offset if alternative treatments
are developed. As public scrutiny of antimicrobials used to treat at-risk animals in feeding
operations escalates, a body of research assessing economic and societal surplus impacts of
eliminating metaphylaxis is essential for making informed policy decisions.
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2.7 Tables
Table 2.1: Feedlot Performance Summary Characteristics for Periods 1 and 2
January 1989-December 2008 Mean Std. Dev. Min Max.
Feed conversion (lb. feed/lb. gain) 6.07 0.59 3.01 9.91
Average daily gain (lb. gain/day) 2.96 0.56 1.51 5.98
Mortality (%) 1.24 1.76 0.00 25.64
Placement weight (lb.) 683.7 128.99 304.20 1,100.00
Days on feed (days) 154.5 44.17 128.00 229.00
Gender Steer 46.0% Heifer 54.0%
Season
Spring 25.1% Summer 27.4%
Fall 24.3% Winter 23.2%
August 2014-December 2015 Mean Std. Dev. Min Max.
Feed conversion (lb. feed/lb. gain) 6.14 0.58 4.29 8.76
Average daily gain (lb. gain/day) 3.24 0.49 1.65 5.18
Mortality (%) 2.54 3.19 0.00 26.78
Placement weight (lb.) 700.8 177.49 301.00 1096.00
Days on feed (days) 192.8 67.20 87.00 443.30
Gender Steer 55.0% Heifer 45.0%
Season
Spring 25.8% Summer 23.2%
Fall 25.8% Winter 25.2%
Notes: N = 48,341 for Period 1. N = 1,321 for Period 2.
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Table 2.2: Feeding Net Return Variables
Variables Description Value/Calculation
Simulated
ADGω,k,τ Average daily gain during feeding (lb./head/day) See equation B.1
AFCω,k,τ Average pounds of feed consumed per pound of
weight gain (lb. feed/lb. gain)
See equation B.2
DOFω,k,τ Number of days on feed (days)
CSWω,k,τ−CPWω
ADGω,k,τ
FCω,k,τ Feed cost ($/head) See equation B.2
HCω,τ Animal health care cost including metaphylaxis,
pull-and-treat, vaccinations, labor costs, etc.
($/head)
See equation B.3
ICω,k,τ Interest cost ($/head) See equation 2.6
MOTω,k,τ Proportion of death loss in purchased group φω,τ
TRω,k,τ Total revenue from cattle sales ($/head) See equation 2.2
Y Cω,k,τ Yardage cost of feeding cattle ($/head) See equation 2.4
ρω,k,τ Net feeding returns ($/head) for each weight (ω),
death loss group (k), and treatment (τ)
See equation 2.1
Fixed
CPWω Cattle purchase weight (lb./head) 550, 700, 850
CSWk Finished animal weight (lb./head) if animal
reaches maturity (e.g., k = alive), 0 otherwise
(e.g., k = dead).
1,350
CULL Proportion chronically ill animals culled from the
remaining cohort
0.014
CULLP Price received for culled animals ($/lb.) 0.75 × FP
CULLW Average weight of culled animals (lb./head) 861
FDRCω Feeder cattle purchase cost ($/head) See equation 2.3
FEED Corn price when cattle are placed on feed ($/lb.) 0.0923
FP Fed cattle sale price ($/lb.) 1.48
FRPω Purchase price for CPW 550, 700, and 850 lb.
($/lb.)
1.70, 1.49, 1.39
IR Annualized interest rate 0.05










































































































































































































































































Table 2.4: Short-Run (1 Year) Producer and Consumer Surplus Estimates of Metaphylaxis
Elimination, 2015





Fed Cattle -924.86** -1,179.85**
Feeder cattle -1,060.78** -1,354.22**




Fed hog 22.36** 28.56**




Fed lamb 0.08** 0.11**
Feeder lamb 0.07** 0.09**




Total poultry producer surplus 829.26** 1,059.14**





Domestic lamb -0.37** -0.47**
Imported lamb 3.81** 4.86**
Poultry 1.44** 1.80**
Total meat consumer surplus -1,074.23** -1,370.51**
Note: Double asterisks (**) indicate significance at the 5% level.























































































































































































Figure 2.2: Simulated Net Return Distributions by Cattle Health Risk and Placement Weight
Note: 550 lb. high-risk cattle lose $104.46/head relative to treated cattle, 700 lb. high-risk
cattle lose $99.26/head, and 850 lb. high-risk cattle lose $63.36/head when not treated with
metaphylaxis. Typical cattle feeding returns over a comparable period across all placement
weights were -$43.39/head (Focus on Feedlots, 2015).
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Chapter 3
Why do livestock producers use
metaphylaxis? Self-insurance vs.
self-protection and a market
insurance alternative
3.1 Introduction
Antimicrobial resistance in humans is a global health concern that causes an estimated
700,000 deaths per year globally (O’Neill, 2016). There is growing public concern from med-
ical and disease-monitoring organizations that inappropriate use of shared class antimicro-
bials in livestock for disease prevention is directly contributing to antimicrobial resistance in
humans (Clifford et al., 2018). Concerns of antimicrobial resistance and antimicrobials used
in livestock for disease prevention has prompted international and national organizations to
further monitor and regulate antimicrobial use in livestock production.
Monitoring efforts have primarily focused on the quantity of antimicrobials sold as a
proxy for antimicrobial use. Antimicrobial sales likely overstate actual production use within
a given year. Several studies show that antimicrobial sales are expected to grow in both de-
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veloped and developing countries (Van Boeckel et al., 2017). It is difficult, if not impossible,
to determine through publicly and privately available data if livestock were given antimi-
crobials for the purpose of disease treatment or prevention. However, livestock producers
use antimicrobials for disease prevention on high health risk animals when morbidity and
mortality rates are expected to be high but animals have not yet shown clinical signs.
Livestock producers use antimicrobials for disease prevention since there are few alter-
native animal health practices to reduce morbidity and mortality rates in high health risk
livestock during feeding. Current alternative disease detection methods are either too vari-
able, not cost effective or both.1 Newly developed technologies are likely to be adopted
first by more efficient producers who maintain low costs through optimal management and
environmental conditions thus using relatively few antimicrobials. New technologies may
have little effect on producers who substitute antimicrobial use for improved environmen-
tal and management conditions (McBride et al., 2008). Thus, few alternative technologies
available to mitigate morbidity and mortality in high health risk livestock meet the World
Health Organization’s goal to provide new medicines, diagnostic tools, vaccines and other
interventions that optimize the use of antimicrobials in livestock production (World Health
Organization, 2018).
Our findings for this study are summarized as follows. First, we find that when market
insurance is not available, feedlots prefer to allocate expenditures towards disease prevention
compared to disease treatment. Second, when an actuarially fair insurance product is of-
fered, producers equalize expenditure behavior shifts from disease prevention towards disease
treatment. Under the assumption that antimicrobials used for disease prevention increases
antimicrobial resistance, market insurance can reduce antimicrobial resistance. Third, we
propose an elementary insurance product and estimate indemnity and break even premium
rates for various cattle types and producer placement decisions. To our knowledge, this is
the first attempt to document the conditions for producer use of injectable antimicrobials
upon arrival and provide a market alternative to solve potential concerns of antimicrobial
1For example, Whisper by Merck and REDI by Precision Animal Solutions are available for cattle and
ADXL320 in chickens have all shown positive results in randomized control trials over visual observation but
rely on calibrated threshold levels that may by livestock population and producer specific.
40
resistance.
We directly contribute to the animal health economics and insurance literature in several
ways. First, we modify existing insurance models and allow metaphylaxis use to enter a
damage function for either the use of disease prevention or disease treatment and not pro-
duction improvement. Then, motivated by the insights that producers prefer self-insurance
(i.e. disease prevention), we show that when an actuarially fair market insurance product is
available producers change behavior towards greater self-protection (i.e. disease treatment).
Finally, we propose and illustrate insights of how an insurance product could be constructed
using a simple elementary insurance contract conditional on realizations of farm-level mor-
tality rates. Combined, this illustrates how antimicrobial use and potentially antimicrobial
resistance could be reduced by providing a market insurance product to feedlots. To our
knowledge, this is the first attempt to document the conditions under which a feedlot uses
metaphylaxis and provides a market alternative to solve consumer and international concern
surrounding antimicrobial resistance.
The remainder of this paper is organized as follows. Section I summarizes current un-
derstanding of injectable antimicrobial use and antimicrobial resistance in cattle feedlots.
Section II presents our conceptual model of self-insurance and self-protection and the proper
identification of metaphylaxis through a damage function. Section III motivates a market
insurance product and provides results based on an elementary insurance contract. Section
IV concludes.
3.2 Antimicrobial Use in Feedlots
Considerable attention has focused on monitoring the use and sales of feed, water, and
injectable antimicrobials. In 2008, the United States Congress instructed the Food and Drug
Administration (FDA) to monitor antimicrobial sales for food producing livestock. Increased
monitoring continued when the United States Congress further required livestock operations
to obtain a veterinary feed directive (i.e. prescription) from a practicing veterinarian to
purchase and use antimicrobials in their operations beginning on January 1st 2017 (United
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States Congress, 2015).
In 2017, the share of antimicrobials used in feed and water decreased but the share of
medically important injectable antimicrobials and non medically important antimicrobials
increased (see figure 3.2). Species specific sales by drug class reveal that cattle producers
have reduced tetracycline use, an antimicrobial used in feed and water, by 45% between
2016 to 2017 but increased macrolide use by 41% (Food and Drug Administration, 2018).
Fluoroquinolone use across all species increased by 24% for which two of the three drugs
available are marketed to treat and control disease in high risk cattle (2018). The animal
health practice of metaphylaxis, injecting FDA approved antimicrobials to high health risk
cattle upon arrival, is a major contributor to both macrolide and fluoroquinolone use.
Producers use metaphylaxis to manage mortality and morbidity in high health risk cattle.
Metaphylaxis is selectively used by 59% of U.S. feedlots on 20.5% of cattle placed on feed
across all cattle placement weights (United States Department of Agriculture, 2013). Meta-
phylaxis is used for two primary purposes: (1) control the amount of morbidity and mortality
in clinically diagnosed high health risk cattle and (2) prevent occurrence of morbidity and
mortality in high health risk cattle that are at an elevated risk to become sick. Thus, meta-
phylactic intervention is used to reduce mortality and morbidity risk, may reduce medication
costs, reduces days on feed, and can improve carcass and offal quality (Schumann et al., 1990,
1991; Van Donkersgoed, 1992; Duff et al., 2000; Encinias et al., 2006; Cernicchiaro et al.,
2012; Tennant et al., 2014).
3.2.1 Antimicrobial Resistance Due to Use Antimicrobial Use in
Feedlots
No information is available about how metaphylaxis impacts antimicrobial resistance. As
the number of times an injectable antimicrobial increases, the percentage of resistant isolates
observed increases linearly (see figure 3.1). Metaphylaxis could increase the number of
antimicrobial resistance isolates but by how much depends on prior antimicrobials received
and the bacteria present in cattle. For example, Magstadt et al. (2018) show antimicrobial
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resistance is most likely to occur when combating Mannheimia haemolytica - increasing 2.5-8
times from no antimicrobial treatments to three antimicrobials treatments. Resistance to
tilmicosin and tulathromycin were present in >75% of Mannheimia haemolytica isolates from
cattle that had received three or more antimicrobial treatments. Some small percentage of
resistant bacteria to Tilmicosin or Tulathromycin are still present even when zero treatments
were given during feeding. This could be as a result of previous health treatments or naturally
occurring loads of resistance bacteria.
Minimizing antimicrobial resistance is a meaningless objective which is best achieved by
not using any drugs at all. Rather the aim should be to cost effectively minimize the to-
tal amount of illness or death. This objective considers both treating livestock today and
minimizing future resistance levels. Inherent in this premise is that some level of resistance
is optimal. Recently, cycling antimicrobial treatments has been talked about extensively
as a viable and cost effective way of reducing antimicrobial resistance in livestock feeding.
Cycling involves rotating between one or a combination of drugs used simultaneously over
various time horizons and aims to reduce selection pressure for resistance bacteria. The key
assumption to cycling is the fitness cost of resistance: the evolutionary disadvantage placed
on resistant strains in an antibiotics-free environment. When fitness cost is high, resistant
bacteria strains dissipate quickly because the evolutionary cost of maintaining resistance is
high. Hence, if resistance to a certain antimicrobial is increasing and has a high fitness cost
then temporally removing an antimicrobial from active use will restore its effectiveness. If
fitness cost is low then antimicrobial effectiveness always decreases and temporally remov-
ing an antimicrobial will have little effect on resistance levels making little sense to cycle
antimicrobial treatments.
Practicing livestock feeding veterinarians suggest that periodically removing a given an-
timicrobial reduces livestock retreatment rates (i.e. a potential proxy for resistance) and
once reintroduced re-treatment rates are once again low. This tends to suggest that the
fitness cost of antimicrobials used in livestock feeding operations is low. If this is correct
then cycling antimicrobials or a market alternative that incentivizes producers to temporally
stop using antimicrobial could be a viable option to reduce antimicrobial resistance burden.
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3.3 Self-Protection vs. Self-Insurance
The motivation behind the use of metaphyalxis has important policy implications due to
the elevated nature of increasing antimicrobial resistance in human health. There is grow-
ing consumer concern that the use/misuse of antimicrobials in livestock production creates
resistant bacteria which are passed on to humans via consumed meat products. Consumer
advocacy groups have repeatedly called for the stop of administering antimicrobials to cattle
not clinically diagnosed. However, the line between when sick animals that either do or
do not manifest clinical signs is extremely blurred. Hence, the duality of reasons for using
metaphylaxis.
In Ehrlich and Becker (1972) seminal paper they develop the theory for the demand
for market insurance conditional on two risk-shifting activities: self-protection and self-
insurance. Self-insurance activities aim to reduce the size of a prospective loss. Self-
protection activities aim to reduce the probability of an unfavorable event occurring. Al-
though many actions affect both the size and probability, people are generally assumed to
behave differently under self-protection and self-insurance.
Our previous discussion suggests that U.S. cattle feedlots use the animal health practice of
metaphyalxis on high health risk cattle for two distinct reasons: (1) to reduce the probability
of morbidity and mortality in cattle that are at-risk to become sick (i.e. self-protection) or
(2) to reduce the size of the loss due to morbidity and mortality in cattle that already show
clinical signs (i.e. self-insurance). In what follows, we show under what conditions feedlots
would use metaphylaxis for disease prevention or disease treatment and whether a market
insurance alternative could modify antimicrobial use behavior.
3.3.1 Self-insurance and Self-protection Utility Maximization Prob-
lem
We focus on U.S. cattle feedlots management of high health risk cattle using metaphylaxis.
We first assume producers are utility maximizers, utility is monotonically increasing in in-
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come (U = U(I), U ′(I) > 0), and producers are risk averse (U ′′(·) < 0).
There are two mutually exhaustive types of high risk cattle that enter feedlots: high risk
cattle that become sick and high risk cattle that remain healthy. Pens of high risk cattle that
remain healthy enter the feedlot with probability (1 − p) and generate income Ie1 = P × Y
where P is the fed cattle price and Y is total pen level finished cattle weight. High risk cattle
that get sick enter with probability p and generate income Ie1 −L where L is the prospective
loss of income due to death and loss of cattle performance. Producers can either self-insure
or self-protect against loss due to cattle sickness and death. Self-insurance implies that the
loss L can be modified through expending some income y with diminishing marginal returns
(L = L(y), L′(y) < 0, L′′(y) > 0). Self-protection implies that p could be modified through
expending some income x with diminishing marginal returns (p = p(x), p′(x) < 0, p′′(x) > 0).
For simplicity, we assume no jointness between self-protection and self-insurance and
a linear cost function (e.g. c(x, y) = x + y). Lack of jointness ensures metaphylaxis can
either be used for self-protection or self-insurance, but not both.2 Given these assumptions,
producers solve their utility maximization problem by selecting the level of income to expend
on self-insurance and self-protection given as
Max
x,y
U = [1− p(x)]U(Ie1 − x− y) + p(x)U(Ie1 − L(y)− x− y) (3.1)
Damage Function
Of importance here is how to define the loss of income L(y) generated from BRD bacterial
infections. Animal health strategies are used to limit the magnitude or probability of damages
rather than increase production. In such cases, these agricultural inputs should enter a
damage function rather than the regular production function (Lichtenberg and Zilberman
1986). This acts to protect rather than increase potential income. These types of damage
functions are common in modeling the effects of pesticide, insecticide, and herbicide use on
crop yields but have not been incorporated into modeling how antimicrobial use modifies
2We recognize that this is a somewhat strict assumption given that metaphylaxis can often be used for
both treatment and prevention.
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livestock production.
We specify a production function Y = Y0G(υ) such that Y is realized total weight gain,
Y0 is potential cattle weight gain, G(υ) is an abatement function, and υ is the bacteria
controlling input. We use a two stage process to examine how the control agent affects
bacteria levels and how remaining bacteria levels subsequently affects cattle weight gain. In
the first stage, magnitude of bacteria infestation (Z) depends on untreated bacteria (Z0) and
the proportion of damage agent controlled by a given level of animal health expenditures
used for self-insurance. The control function C(y) is the fraction of maximum bacteria that
is abated (i.e. reduced or removed). Thus, the magnitude of bacterial infestation after the
control agent has been applied is given as
Z = Z0[1− C(y)] (3.2)
The control function is assumed to follow a cumulative distribution (C(y) ∈ (0, 1)). When
C(y) = 1, the control agent(s) completely eliminates all bacteria (Z = 0). When the control
C(y) = 0, the control agent has no effect on the bacterial load.
The second stage models the effect of the remaining bacteria on cattle performance given
by
Y = Y0[1−D(Z)] (3.3)
where Y is total cattle weight for a given level of damage agent Z, and Y0 is the level of cattle
weight that would be forthcoming if no damage agent were present. The damage function
D(Z) represents the fraction of total weight lost due to bacteria. The damage function
follows a cumulative distribution where with no bacteria (Z = 0), D(Z) = 0 and actual
cattle performance will be equal to potential cattle performance (Y = Y0).
Substituting the control function, equation 3.2, into the damage function, equation 3.3,
we obtain the production function
Y = Y0[1−D{Z0[1− C(y)]}] (3.4)
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We assume that increases in bacteria reduces cattle weight since cattle need to devote more
energy to fighting bacteria than growing (∂D/∂Z0 > 0) and in extreme cases results in cattle
death which completely eliminates cattle to be sold. Control agent expenditures used for
self-insurance reduce bacteria populations (∂D/∂C < 0) and increases the percentage of
bacteria controlled (∂C/∂y > 0).
3.3.2 Self-protection and Self-insurance when cattle health insur-
ance is not available
Equation 3.1 can be modified to include how bacteria damages total cattle weight as
Max
x,y
U = [1−p(x)]U(PY0[1−D{Z0[1− C(y)]}]︸ ︷︷ ︸
Ie1




When high health risk cattle are healthy, bacteria does not cause any damage (D = 0) and
realized cattle weight equals potential cattle weight (Y = Y0). When high health risk cattle
get sick, revenue Ie1 is reduced by some loss (L(y)) when bacteria damages potential yields
(D > 0) resulting in actual yields lower than potential yields (Y0 < Y ). Feedlots attempt to
control cattle weight loss due to bacteria by y self-insurance expenditures. Thus, loss L(y)
is given by PY0[1−D{Z0[1− C(y)]}]. Given this, equation 3.5 equation is rewritten as
Max
x,y
U = [1− p(x)]U(PY −x− y) + p(x)U(PY −PY0[1−D{Z0[1− C(y)]}]︸ ︷︷ ︸
L(y)
−x− y) (3.6)
The first order optimality conditions are
Ux : p
′(x)U(I1) + (1− p(x))U ′(I1)− p′(x)U(I0) + p(x)U ′(I0) = 0 (3.7)
Uy : (1− p(x))U ′(I1) + p(x)U ′(I0) + p(x)U ′(I0)L′(y) = 0 (3.8)
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where I1 = I
e
1−x−y, I0 = Ie1−L(y)−x−y and L′(y) = Y0D′(·)Z0C ′(y). Equating equations







The right hand side represents the reduction in expected loss due to self-insurance relative
to self-protection activities. Assuming a risk averse agent (U ′′(·) < 0) implies that the left
hand side is less than one.3 Likewise, this implies that the right hand side must be less than







where L(x, y) ≡ p(x)L(y) is the expected loss. Equation 3.10 implies that the last dollar
spent on self-insurance causes a greater reduction in the magnitude of the expected loss than
the last dollar spent on self-protection. This suggests that self-protection causes a greater
reduction in the variance of expected loss (income) relative to self-insurance where both
cause an equal increase in expected revenue. In other words, for a risk averse individual
self-protection would have a greater increase in expected utility relative to self-insurance.4
This does not imply self-protection is preferred to self-insurance since in equilibrium
both are equally preferred. Preferences for self-protection relative to self-insurance would be
determined by the functional forms of p(x) and L(y). Given how L(y) is specified via the
damage function this suggests that when metaphylaxis is used as an animal health protocol
for high risk cattle, producers marginally allocate more expenditure to prevent rather than
treat disease.





2U ′′(Ī). This is then rewritten as [U(I1)−U(I0)]L < U
′(I0) and U
′′(·) < 0
4Our assumption of jointness (i.e. metaphylaxis is used for either disease treatment or disease prevention)
is a critical assumption here.
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3.3.3 Self-insurance and self-protection when a market insurance
is available
In this section we show how feedlots change their marginal self-insurance and self-protection
expenditure behaviors when an actuarially fair insurance product is available to purchase.
We define an insurance product s that aims to reduce the gap between incomes generated





1 − L(y)) and is sold at a unit price π (Chang and Ehrling 1986). Given a
competitive market where self-protection is perfectly observed and no insurance transaction
costs exist, the actuarially fair insurance price which reflects true odds of a loss by any
producer would be given by π(x) ≡ p(x)
1−p(x) . Given these assumptions equation 3.6 becomes
Max
x,y,s




The first order optimality conditions are
Ux : −(1− p(x))U ′(I1)[1 + sπ′(x)]− p(x)U ′(I0)− p′(x)(U(I1)− U(I0)) = 0 (3.12)
Uy : (1− p(x))U ′(I1) + p(x)U ′(I0)[1− PY0D′(·)Z0C ′(y)] = 0 (3.13)
Us : −(1− p(x))U ′(I1)π(x) + p(x)U ′(I0) = 0 (3.14)
where π′(x) ≡ p
′(x)
(1−p(x))2 . From equation 3.14 we know that marginal utilities across both
states are equal thus making incomes equal across both states when a market insurance is
available. Likewise, it follows that equations 3.12 and 3.13 can be combined and simplified








Comparing equations 3.9 and 3.15 we see that in equilibrium when an actuarially fair in-
surance is offered it will move expenditure away from self-insurance towards self-protection.
This implies that an actuarially fair insurance can cause producers to move away from using
metaphylaxis as disease prevention towards using metaphylaxis for disease treatment of high
health risk cattle.
3.3.4 Antimicrobial Resistance as a Public Health Externality and
Government Subsidies on Insurance
Antimicrobial resistance as a public health externality is the key assumption to justify the
use of an insurance product as an alternative to metaphylaxis in high health risk risk feedlot
cattle. As the value of this externality increases, so does the potential for government inter-
ventions through subsides. Higher government subsidies would result in lower premium rates
and thus potential increase in adoption of proposed insurance policies. For example, higher
government subsidies are generally thought to have increased crop insurance participation
(Coble and Barnett, 2012). As the public externality value decreases, it becomes increasingly
difficult to politically justify to use of a government subsidy.5
Current public and medical opinion suggests that (1) antimicrobial resistance is a public
externality and (2) antimicrobial use in livestock production should decrease. Given these
sentiments, acceptance of an insurance policy as a replacement for antimicrobial use seems
viable. However given these sentiments some may negate the idea of using an insurance
product in favor of a direct tax on antimicrobial use. While this would reduce antimicrobial
use by increasing the cost of an antimicrobial, it does little to address producer decision
making surrounding metaphylaxis use, namely to manage high health risk cattle upon arrival
at feedlots. An insurance product as an alternative directly address this behavior while
simultaneously reducing antimicrobial use.
5Our previous derivation has excluded the possibility of a subsidy to incentivize adoption of an insurance
policy. Greater subsidies may increase adoption rates as seen in crop insurance.
50
3.4 Cattle Health Market Insurance
Previous sections supported two facts: (1) in the absence of market insurance cattle produc-
ers will marginally expend more income on disease prevention (i.e. self-insurance) compared
to disease treatment (i.e. self-protection) and (2) if an actuarially fair market insurance
were available producers would marginally shift income away from self-insurance towards
self-protection. These two facts establish both the need and demand for cattle health insur-
ance. Further, it directly aligns with the objectives of the World Health Organization that
alternatives to antimicrobial use in livestock production should be developed.
Various fed-cattle insurance products are currently offered by private and public agencies.
Public forms of fed cattle insurance offered by the United States Department of Agriculture
(USDA) include Livestock Risk Protection (LRP) and Livestock Gross Margin (LGM). Live-
stock Risk Protection offers protection against declining market price. If the actual ending
value is below the coverage price, producers receive an indemnity payment for the difference
between the coverage price and actual ending value. Livestock Gross Margin protects an
expected gross margin rather than a selling price, as is the case with LRP. Both products do
not cover losses due to cattle due to morbidity or mortality. Further, no cattle can be insured
during the first month of any insurance period making them problematic for producers to
use in lieu of metaphylaxis which is given to high health risk cattle upon arrival.
Private forms of herd level fed cattle insurance include both comprehensive coverage for
accidents, sickness, disease, and injury and limited coverage for accidents, weather events,
natural disasters, and transportation.6 Comprehensive coverage includes losses due to fed
cattle mortality and morbidity but have pre-existing condition clauses. Pre-existing condi-
tions of sickness or impaired health condition make livestock ineligible to be covered. Thus,
fed cattle insurance products are used to manage low health risk cattle which have relatively
low amounts of mortality and morbidity. There is currently no product that is available for
producers to use to manage the mortality and morbidity risk in high health risk cattle.
6For example, Nationwide and Hartford offer various forms of feedlot and pasture insurance products to
producers
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3.4.1 Cattle Health Insurance Experimental Design
Various combinations of cattle types, health protocols, antimicrobials used, and health out-
comes create an enormous number of potential insurance combinations that cannot be com-
prehensively analyzed here. Rather, we focus on three broad groups of high health risk cattle
purchased by feedlots and two animal health protocols - 550lb., 700 lb., and 850 lb. feeder
cattle and metaphylaxis or do-nothing (i.e. no metaphylaxis).
For simplicity I assume that an insurance product is written for one producer rather than
developing an index product that is more geographically diverse. The primary disadvantage
is that this product would be extremely information intensive and more difficult to transfer
risk to capital markets. However, it does avoid basis risk which results from imperfect
correlation between individual outcomes and insurance indices (Martin et al., 2001; Yu et al.,
2019). Additional variations could explore how a Midwestern index insurance product could
be developed.
3.4.2 Design and Pricing of Cattle Health Insurance
We restrict our attention to elementary insurance contracts which pay an indemnity based on
a realized value and have been used in numerous agricultural studies to price various forms
of index insurance (Changnon and Changnon, 1989; Patrick, 1988; Turvey, 1999). Since
elementary contracts are quite simple they are convenient for analysis but can be layered to
create complex structures of risk protection. We modify the elementary contract proposed
by Martin et al. (2001) who created a European call option and whose indemnity function
is given as
indemnity(x|strike, limit, liability, cattle) = liability×

0 if x < strike,
x−strike
limit−strike if limit > x > strike,




where strike, limit, liability, and cattle are all choice variables made by the feedlot. Strike
is the minimum death loss needed for the contract to pay, limit is the maximum death loss
the contract will pay out for, liability is the maximum possible indemnity payment, and ‘x’
is some pen level realization of BRD related death loss (i.e. % of pen that died). Each call
option created is conditional on the type of cattle placed where cattle are the three different
cattle placement weights - 550 lb., 700lb., and 850lb. Indemnity values are obtained for a
combination of strike, liability, limit, and specific realization of death loss ‘x’ using equation
3.16.
The loss cost is the portion in the underbrace and equation 3.16 can be rearranged to
show that it is equal to indemnities divided by liabilities. Expected loss costs are used
by insurance companies to establish insurance premium rates and can be considered as
the expected breakeven premium rate (Skees and Barnett, 1999; Martin et al., 2001). We
calculate the breakeven premium rate for the proposed call option as the unconditional
expectation of the loss cost.
These types of elementary contracts allow feedlots to obtain a unique contract every
time a new strike, limit, and maximum liability level is chosen. To illustrate, consider a
hypothetical elementary contract written for the total percent of death loss measured for a
specific pen located at a specific feedlot. For simplicity assume that the producer is placing
a 850 lb. feeder steer with a feeder price of $1.47 per lb. Suppose the producer selects an
insurance contract with strike price of 5 %, 25% limit, and maximum indemnity of $1000 per
head ((1000/(1.47× 850))× 100 = 80% of potential income per head). If the pen level death
loss during that time on feed was 3% (i.e. below the strike) then the contract would pay
nothing. However, if pen level death loss was 27% (i.e. above the limit) then the contract
would pay $1000 per head. Finally, if death loss was 20% then the contract would pay $750
per head (1000× 20−5
25−5 = 750).
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3.4.3 Pricing Livestock Health Insurance
In order to price an elementary contract, contract parameters as well as mortality probability
distribution should be known. The mortality distribution of high health risk cattle given
metaphylaxis can be estimated from data. Previous work suggests that these mortality
distributions follow a log-normal or gamma distribution (Babcock et al., 2009). We estimate
mortality distribution of high health risk cattle given metaphylaxis as log normal using
pen level proprietary data from 10 Midwestern feedlots that placed high health risk cattle
between 2014 and 2015 and subsequently administered metaphylaxis. Mortality distributions
for cattle that did not receive metaphylaxis are not observed in proprietary data but are
obtained by multiplying the mortality distributions of high health risk cattle that received
metaphylaxis by an odds ratio. Odd ratio’s for high health risk cattle that did not receive
metaphylaxis are obtained from Abell et al. (2017).
The objective of the elementary contract is to provide feedlots a market alternative to
manage the additional mortality risk incurred by not using metaphylaxis. It does not cover
all mortality risk inherent in high health risk cattle. We obtain the probability distribution
of this additional mortality risk by differencing the no metaphylaxis and metaphylaxis mor-
tality probability distributions. This differenced death loss distribution is obtained in the
following manner. First, approximate the probability density function (PDF) for no meta-
phylaxis and metaphylaxis as previously discussed. Second, at each value of death loss there
is an associated probability. Difference the probability of obtaining a given death for no
metaphylaxis and the probability of obtaining that same death loss value for metaphylaxis.
What remains is the difference in probabilities at a given death loss. Third, only keep values
of death loss where this differenced probability is positive.7 Fourth, re-scale the death loss
values from zero to D − C, where D is the maximum loss value for both of the underlying
distributions and L is the death loss value where P (no metaphylaxis)−P (metaphylaxis) > 0.
This new differenced distribution represents the probability of obtaining a death loss over
7We constrain this to be any positive probability where death loss is greater than 1% (i.e.
P (no metaphylaxis) − P (metaphylaxis) > 1). This smooths the distribution by eliminating jumps and
discontinuities that generally occur when death loss is less than one.
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a pen of cattle that were managed with metaphylaxis. For example, suppose we have a 550
lb. high health risk placement and observe a 1% death loss with probability 0.03 on this new
differenced distribution. This would imply that we have a 3% probability of having a death
loss 1% higher then we would have had if metaphylaxis had been used. This new differenced
distribution is grounded in our previous theoretical model which suggests that producers
would be willing to allocate marginal income towards using disease treatment (i.e. pull and
treat only those animals which are sick) if a market insurance were available.
Figure 3.3 displays this differenced mortality distribution for high health risk cattle across
three different different placement weights. As placement weight increases, we are less likely
to obtain differences in death loss between using metaphylaxis and not using metaphylaxis.
This is consistent with observed data that finds that the effectiveness of metaphylaxis man-
aging mortality and morbidity increases as cattle placement weight decreases. There is still
some probability of obtaining large death losses above metaphylaxis across all placement
weights.
After fitting the differenced log-normal distribution by cattle placement weight as shown
in figure 3.3, we calculate the expected loss cost by integrating over the loss cost function in












If x < strike then no indemnity is paid out.
3.4.4 Potential Issues with a Mortality Insurance Contract
Additional attention should be given to the amount of information that would be required in
order to price such a contract and the differences between developing this contract and crop
insurance. First, historical BRD death loss is required on pens of cattle given metaphylaxis.
This implies that producers (1) use metaphylaxis, (2) keep pen level animal health infor-
mation, and (3) have individual death records were deaths are confirmed by a veterinarian.
Second, this type of information are privately held and feedlots generally started collecting
55
this information within the past 10 years. This is distinctly different from crop insurance
where county level yields are publicly available. No monthly or yearly cattle data are pub-
licly available to use. Combined, these two overarching concerns pose significant constraints
on both the implementation and adoption of this any other insurance products.
The insurance product proposed is for three placement weights across an average sex,
season, and antimicrobial used. Chapter 1 suggests that the value of metaphylaxis varies
by sex, season, placement weight, and antimicrobial used. This implies that estimated
premiums represent an “average premium”. To further incorporate this increased amount of
heterogeneity in both cattle and producer decisions into insurance premiums would further
increase the burden of historical information such as providing antimicrobial specific lot level
health information.
While incorporating heterogeneity is beneficial for accurate premium rates it has the
potential to impact producer decision making. For example, the insurance contract proposed
in equation 3.16 could further include a decision of antimicrobial that would be used (i.e.
Draxxin, Micotil, etc.). Premium rates conditional on antimicrobial choice, while more
accurate, create the potential for adverse selection where producers purposely mismatch
antimicrobial and cattle type.8. Thus, the trade-off for the insurance provider is whether the
gain from accurate premium rates outweighs the added cost from adverse selection which
ultimately is an empirical question.
Moral hazard and adverse selection are two significant concerns in designing any insurance
contract. Moral hazard occurs when feedlots change behavior after purchasing an insurance
contract. Adverse selection occurs when only extremely high risk cattle are enrolled and
indemnity payments are likely to be high. Counter-intuitively, the proposed insurance con-
tract potentially encourages the enrollment of cattle to allow producers to substitute away
from antimicrobial use. Moral hazard and adverse selection would then be priced into the
contract increasing premium rates and potentially requiring the use of government subsidies
to offset higher costs. Thus, while the use of government subsidies do not “fix” these prob-
8It is known that producers match the strength of the antimicrobial with cattle health. For example, an
upper tier antimicrobial is used on cattle where significant mortality and morbidity is expected.
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lems, it does allow sufficient time for insurance contract to be properly calibrated (Coble
and Barnett, 2012).
Of these two issues, we believe that adverse selection is the greater problem for several
reasons. First, adverse selection is difficult, if at all, observable by the insurance provider.
Adverse selection primarily occurs when cattle are initially enrolled. One solution to the
potential mismatch of cattle and antimicrobials is to standardize how veterinarians catego-
rize high health risk cattle and which drugs should be administered. Cattle enrolled in a
contract would need to meet a certain “numerical score” in order to qualify for contract
participation. Based on that numerical score an associated list of antimicrobials that could
then be selected.9 While this would potentially alleviate mismatch concern, creating agree-
ment on a high health risk scale is difficult and categorizing antimicrobials posses significant
industry and professional push back. Second, we believe the moral hazard to be a function of
innovation and posses a sinusoidal functional form. Given this functional form, moral hazard
would then be bound by the chosen strike and limit. Low amounts of moral hazard occur
when death loss is below the strike. As death loss increases above the strike, the incentive
to increase moral hazard behavior changes, first at an increasing then at a decreasing rate
until the limit is reached. As death loss approaches the limit the more producers desire to
innovate since indemnities are only paid up to the limit and not beyond. These innovations
would have a potential spillover effect as producers incorporate this knowledge in managing
future high health risk cattle.
3.5 Results
In order to calculate the losses associated with each class of cattle we make some simplifying
assumptions. First, we assume that all cattle death occurs within the first day on feed.Thus,
feed, yardage, health, and interest costs are negligible. Second, we use a five year average
for medium and large frame #1 steers from combined Nebraska auctions (LMIC 2019). We
9This approach is similar to antimicrobial “tiers” proposed by Abell et al. (2017) where antimicrobials
are classified based on their respective efficacy to reduce morbidity and mortality in high health risk cattle.
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assume these prices are representative of feeder prices for the United States. Prices for 550
lb., 700 lb., and 850 lb. feeder cattle are $1.8122, $1.5951, and $1.4706 per lb., respectively.
Losses per head are obtained by multiplying placement weight by the respective feeder cattle
price. Estimated per head losses by cattle weight are given in table C.1 in appendix C. Linear
losses per head are calculated as $997, $1,117, and $1,250 for 550 lb., 700 lb., and 850 lb.
cattle placements, respectively. Higher losses with higher placement weights reflects the
increased cost of the feeder cattle.
Each call option measures death loss at the pen level. We use a pen size of 120 head
which is the average pen size managed in our proprietary data. To obtain cattle type specific
liability levels, we multiply the number of each in each pen by the value of metaphylaxis. The
value of metaphylaxis is the average net return per head that producers forgo be choosing not
to administer metaphylaxis. The value of metaphylaxis per head is cattle type specific and
taken from Dennis et al. (2018). The value of metaphylaxis per head for 550 lb., 700 lb., and
850 lb. feeder cattle placements is $104.46, $99.56, and $63.36, respectively. Thus, we obtain
cattle type specific liability levels for 550, 700, and 800 lb. feeder cattle are $12,535.20 (120×
104.46), $11,911.20 (120× 99.26), and $7,603.20 (120× 63.36) respectively. Lower liabilities
levels are associated with heavier placement weights reflective of the lower additional risk
incurred by not using metaphylaxis. Costs are obtained by multiplying breakeven premium
rates by liability. Indemnity values are given for a specific realization of death loss ‘x’ using
equation 3.16.
Table 3.1 displays breakeven premium rates and breakeven costs for a chosen strike and
limit and indemnities for a chosen strike, limit and realization of ‘x’. While numerous
combinations are theoretically feasible, we focus on common death loss occurrences across
differing cattle placement weights. Breakeven rates are obtained by taking the unconditional
probability for each choice of strike and limit from the differenced distributions in figure
3.3. Breakeven costs ($) are obtained by multiplying the breakeven premium rate by the
maximum liability level. Indemnities ($) are obtained using equation 3.16. For example, the
breakveven costs for strike 5 and limit 15 (i.e. row 3) is $3,306 (26.37/100× 104.46× 120).
For a death loss realization of 8, the indemnity paid out is $3,761 ((8−5)/(15−5)×104.46×
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120). Breakeven costs (indemnities) range from $1,433-$3,468 ($1,880 - $12,535), $819-$5,256
($1,787 - $11,911), and $199-$3,051 ($1,140 -$7,603) for 550, 700, and 850 lb. feeder cattle
respectively.
Various combinations of strike and limit in conjunction with actual death loss realizations
are possible. The benefit of the mortality call depends on these realizations. For example,
for 550 lb placement $3,306 is the breakeven costs for a $12,535.20 call with a strike of 5
and limit of 15. If the pen realized a death loss of 8 then the call would pay an indemnity
valued at $3,761 ( 8−5
15−5 × 12535). This is below the expected losses of $7,974 (see table C.1;
1.8122 × 550 × 8) or about 47% of the loss (3306/7974). However, given a call of strike 5,
limit 10, and the same death loss realization of 8, the breakeven costs would be $3,468 and
the call would pay $7,521, nearly 100% of the loss (7521/7974).
In order to spread out the potential mortality liability a feedlot could elect to purchase
multiple call options. For example, the feedlot that purchases 850 lb. high risk cattle
could purchase a call with strike 5 and limit 20 and a call with strike price 5 and limit
10. This would have a breakeven cost of $2,398 (see column 9 rows 2 and 4 table 3.1;
[27.67/100× 63.36× 120] + [23.64/100× 63.36× 120]) and offer the feedlot $6,083 of liability
(see column 12 rows 2 and 4 in table 3.1; [ 8−5
10−5 × 63.36× 120] + [
8−5
20−5 × 63.36× 120]) for a
death loss realization of 8. This would cover about 60% of the losses. This allows producers
to create levels of protection against cattle mortality not possible under traditional forms of
insurance.
3.5.1 Expected Utility Analysis
We test the efficiency of our mortality call using an expected utility analysis. We assume a
risk averse feedlot that has a 60,000 head one time capacity feedlot, turns its feedlot twice
per year, and derives wealth solely from marketing cattle. The feedlot places 1000 pens of
cattle with 120 head of cattle in each pen (i.e. this feedlot markets 120,000 head per year
(120×1000)). Assuming a feeder price of $1.8122, $1.5951, and $1.4706, initial feedlot wealth
is $4,977,500 (1.8122× 550× 5000), $6,335,000, and $7,692,500 if all cattle are 550 lb., 700
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lb., or 850 lb., respectively (see panel (a) of table 3.2). We assume the feedlot can take one
of three actions: (a) do-nothing which is equivalent to not using metaphylaxis, (b) select a
call with strike 5 and limit 10, and (c) select a call with strike 10 and limit 20.
Our wealth simulation is conducted as follows:
1. Draw a death loss for a pen of high risk cattle that received metaphylaxis from the
proprietary data;
2. Multiply death loss by the odd ratio to obtain expected death loss of cattle that did
not receive metaphylaxis;
3. Difference the death loss obtained in step 2 and step 1;
4. Using this death loss, calculate whether an indemnity that is paid out, if any, based
on the producer animal health strategy; and
5. Repeat steps 1-4 1000 times.
The feedlot’s expected utility over wealth is assumed to be given by a utility function
with constant risk aversion. While many utility functions could theoretically be used, we
elect to use the power utility function with constant relative risk aversion where utility over





where U is utility, Ω is initial wealth, and r is a risk aversion coefficient. The certainty





An r < 0 implies risk aversion with larger absolute values inferring a stronger attitude
towards risk. The certainty equivalence represents the minimum amount of money that is
required to be paid to feedlots to forgo a risky alternative and is the standard for measuring
insurance product efficiency.
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Mean ending wealth, standard deviation, maximum, and minimum wealth across different
cattle placement weights and scenarios is given in panel (b) of table 3.2. On average, ending
wealth is higher with less variation in wealth. When either of the mortality calls are used the
minimum wealth obtained is greater than under a do-nothing strategy. Thus, the mortality
call helps to protect producers from downside risk. Table 3.2 panel (b) display certainty
equivalents obtained from equation 3.19 for the negative exponential utility function under
the three different scenarios: (a) do-nothing, (b) call with strike 5 and limit 10, and (c) call
with strike 10 and limit 20. All certainty equivalents are larger when the feedlot chooses to
purchase either of the mortality calls. 10
3.6 Conclusions
In this study, we investigated the conditions under which livestock producers use antimi-
crobials for disease prevention or disease treatment. Specifically, we focused on US cattle
feedlots and their use of metaphylaxis, administration of injectable FDA approved antimi-
crobials to sick or at-risk feeder cattle upon arrival. We focused on metaphylaxis since it
is one of the only animal health strategies feedlots have to manage high health risk cattle
upon arrival and has been targeted to be further regulated by the European Union. Further,
metaphylaxis is encompassed under the World Health Organizations goal to reduce or re-
move the use of shared-class antimicrobials for disease prevention without individual animal
diagnosis (World Health Organization, 2018).
The World Health Organization has encouraged the development of new medicines, di-
agnostic tools, vaccines and other interventions that optimize the use of antimicrobials in
livestock production. Few products are currently cost effective or reliable to manage mor-
bidity and mortality risk in health health risk livestock. Our study shows that cattle pro-
10Certainty equivalents can vary based upon the utility function used. To verify our finding that for a
risk averse feedlot certainty equivalents are higher under our mortality call option we find the certainty
equivalents under a power utility function when r = 1. The certainty equivalents across the three weights
and three strategies are as follows: 550 lbs. (989,191; 994,591; 990,480), 700 lbs. (1,108,987; 1,112,809;
1,111,301), and 850 lbs. (1,244,883; 1,246,476; 1,245,032) for do-nothing, strike 5 limit 10, and strike 10
limit 20, respectively.
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ducers will use marginal income towards disease prevention rather than disease treatment
but equalize income when an actuarially fair insurance product is offered. We then propose
an elementary insurance product that could be marketed to livestock producers. As antimi-
crobial resistance continues to be a growing human health concern finding alternatives to
antimicrobial use becomes elevated. The product we introduced has the potential to reduce
antimicrobial resistance if antimicrobial fitness costs are high.
The more market and technology substitutes for antimicrobial use in livestock produc-
tion the more likely producers can adopt these potentially reducing antimicrobial resistance.
These results help inform industry stakeholders and policy makers about potential market
insurance contracts that can be created. As concerns over antimicrobial resistance and an-
timicrobial use in livestock rises greater pressure to provide alternatives will rise. A body
of research needs to be developed to provide market alternatives to antimicrobial use meta-












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3.2: Ending Wealth and Certainty Equivalents for Different Mortality Call Scenarios
Mortality Call Scenario
Do-nothing Strike 5, Limit 10 Strike 10, Limit 20
Panel (a): Inital Wealth ($)
550 lb. 996,710 996,710 996,710
700 lb. 1,116,570 1,116,570 1,116,570
850 lb. 1,250,010 1,250,010 1,250,010
Panel (b): Ending Wealth ($)
550 lb.
Mean 989,200 994,600 990,500
Std. Dev. 5,500 3,143 3,303
Min 956,700 969,200 969,200
Max 996,700 999,300 996,700
700 lb.
Mean 1,109,000 1,113,000 1,111,000
Std. Dev. 6,796 3,187 3,605
Min 1,089,000 1,101,000 1,105,000
Max 1,117,000 1,117,000 1,118,000
850 lb.
Mean 1,245,000 1,246,000 1,245,000
Std. Dev. 4,791 2,520 4,449
Min 1,234,000 1,242,000 1,236,000
Max 1,250,000 1,250,000 1,250,000
Panel (c): Certainty Equivalent when r = 1 ($)
550 lbs. 956,663 969,198 969,198
700 lbs. 1,089,353 1,101,264 1,105,553
850 lbs. 1,234,384 1,241,988 1,236,285
Note: Certainty equivalents are obtained for a negative exponential utility function.
65
3.8 Figures
Figure 3.1: Antimicrobial Resistance by Number of Treatments
Source: Magstadt et al. (2008)
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Figure 3.2: Domestic Sales and Distribution of Antimicrobial Drugs Approved for use in
Food-producing Animals and Actively Marketed by Route of Administration, 2009-2017
Source: Food and Drug Administration (2009:2017)
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Figure 3.3: Difference in Death Loss Between No Metaphylaxis and Metaphylaxis
Source: Proprietary Feedlot Data (2014-2015)
Note: All distributions can be modeled as Beta distributions and the two shapes are given
as: 550 lb (1.19, 273.52), 700 lb. (0.46, 55.37), and 850 lb. (0.36, 55.14)
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Table A.1: Feeding Net Return Variables
Variables Description Value/Calculation
Simulated
ADGω,k,τ Average daily gain during feeding (lb./head/day) See equation B.1
AFCω,k,τ Average pounds of feed consumed per pound of
weight gain (lb. feed/lb. gain)
See equation B.2
DOFω,k,τ Number of days on feed (days)
CSWω,k,τ−CPWω
ADGω,k,τ
FCω,k,τ Feed cost ($/head) See equation B.2
HCω,τ Animal health care cost including metaphylaxis,
pull-and-treat, vaccinations, labor costs, etc.
($/head)
See equation B.3
ICω,k,τ Interest cost ($/head) See equation 2.6
MORTω,k,τ Proportion of death loss in purchased group φω,τ
TRω,k,τ Total revenue from cattle sales ($/head) See equation 2.2
Y Cω,k,τ Yardage cost of feeding cattle ($/head) See equation 2.4
πω,k,τ Net feeding returns ($/head) for each weight (ω),
death loss group (k), and treatment (τ)
See equation 2.1
Fixed
CPWω Cattle purchase weight (lb./head) 550, 700, 850
CSWk Finished animal weight (lb./head) if animal
reaches maturity (e.g., k = alive), 0 otherwise
(e.g., k = dead).
1,350
CULL Proportion chronically ill animals culled from the
remaining cohort
0.014
CULLP Price received for culled animals ($/lb.) 0.75 × FP
CULLW Average weight of culled animals (lb./head) 861
FDRCω Feeder cattle purchase cost ($/head) See equation 2.3
FEED Corn price when cattle are placed on feed ($/lb.) 0.0923
FP Fed cattle sale price ($/lb.) 1.48
FRPω Purchase price for CPW 550, 700, and 850 lb.
($/lb.)
1.70, 1.49, 1.39
IR Annualized interest rate 0.05
SHRINK Proportion shrink in live weight when marketed 0.04
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Table A.2: Death Loss Distributional Assumptions for Cattle Type and Antimi-
crobial Treatment
Antimicrobial Placement Weight Season Meana St. Dev.a
Upper Tier 600 Summer 1.07 0.91
Upper Tier 600 Winter 1.36 1.23
Upper Tier 800 Summer 0.94 0.55
Upper Tier 800 Winter 1.57 0.54
Lower Tier 600 Summer 4.14 3.77
Lower Tier 600 Winter 5.26 5.08
Lower Tier 800 Summer 3.66 2.30
Lower Tier 800 Winter 6.10 2.24
No Metaphylaxis 600 Summer 6.68 6.49
No Metaphylaxis 600 Winter 8.49 8.75
No Metaphylaxis 800 Summer 5.90 3.96
No Metaphylaxis 800 Winter 9.83 3.87
a To account for endogenous producer decisions in using specific antimicrobials
on specific cattle populations , we use the odd ratios from Abell et al. (2017) for
the lower tier antimicrobial and the death loss observed in lower tier antimicro-
bials to solve for the death loss of the control. We then use this control death
loss and the odd ratios for the upper tier antimicrobial to obtain the death
loss for the upper tier antimicrobial. This allows us to obtain the death loss of
different antimicrobials on different cattle populations. A similar producer was




B.1 (A) Cattle Mortality
Metaphylaxis is effective in helping reduce feedlot mortality, but efficacy varies by drug,
placement weight, location, season, and animal health risk. In randomized-control studies
testing the effectiveness of metaphylaxis, using the commonly administered macrolide called
Tilmicosin on high-health-risk cattle, mortality has varied considerably across treatment and
control groups. For example, in control studies of metaphylaxis, Vogel et al. (1998) realized
death losses of 1.65% in the treatment group and 4.18% in the control group; Corbin et al.
(2009) found 7.50% treatment, 13.50% control; and Tennant et al. (2014) observed 1.40%
treatment, 3.07% control.1
In a recent meta-analysis, Abell et al. (2017) reviewed 29 randomized-control trial stud-
ies of metaphylaxis use in cattle and estimated odds ratios for various types of metaphy-
lactic drugs. Odds ratio estimates were weighted by U.S. Department of Agriculture (2013)
metaphylaxis drug application rates for two commonly used macrolides, Tilmicosin and Tu-
lathromycin, to obtain industry efficacy rates. On average, not administering metaphylaxis
to high-risk cattle increased mean mortality (standard deviation) 2.43 (5.57) times. While
1Individual randomized controlled trials are limited in their ability to generalize the magnitude of reduc-
tion in mortality associated with metaphylaxis treatments, particularly across season and weights, due to
experimental design costs and small sample sizes.
80
expected mortality distribution of a group of cattle may be approximated, exact mortality
risk present at cattle purchase and subsequently modified through a health management
practice is only realized after feeding.
Mortality in cattle feeding is directly observed ex post and constitutes the largest observed
health-risk cost outcome. Death loss in feedlots is conditional on cattle health-risk category
and animal placement weight and can be modified with health management practices. Mor-
tality distributions are generally observed to be right-skewed with long tails, approximated
using a log-normal, (zero-inflated) negative binomial or a (zero-inflated) Poisson distribu-
tion and conditioned by placement risk category, weight, season, gender, location, and breed
(Babcock, 2010). Mortality data used in this article follow a log-normal distribution but can
also be adequately modeled using a gamma distribution.
Based on Babcock (2010), we calibrate a unique lognormal death-loss distribution for
each of the six weight-by-treatment high-health-risk cattle groups: three cattle types (550
lb., 700 lb., and 850 lb. placement weights) and two health treatments (metaphylaxis or no
metaphylaxis). Mortality distributions for high-health-risk cattle treated with metaphylaxis
were estimated using feedlot data. Mortality distributions for high-health-risk cattle not
treated with metaphylaxis were based on estimates from Abell et al. (2017).2 Figure 1
displays the distributional assumptions and generated mortality distributions across cattle
types and health treatments (φω,τ ).
B.2 (B) Cattle Morbidity
The general state of morbidity is associated with cattle gender, breed, arrival weight, location,
health treatment, arrival month, risk classification, pen size, feedlot size, and animal handling
practices (Nickell and White, 2010). Historical data on morbidity are not generally available
2Since efficacy varies by drug type, death loss odds ratios reported by Abell et al. (2017) were adjusted to
reflect the percentage of cattle administered each type of metaphylatic drug (U.S. Department of Agriculture,
2013). Assuming drug efficacy and treatment administration are constant across weight categories, we
calculated a weighted mean and standard deviation odds ratio. Taking the inverse of the odds ratio yields
a normally distributed metaphylaxis efficacy multiplier. Multiplying these by the observed feedlot mortality
rates for each weight category treated with metaphylaxis provides a normal mean and standard deviation
for mortality.
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in cattle feedlot data but are discernible in readily available animal performance data. Higher
levels of morbidity are associated with lower average daily gain, increased veterinary costs,
more frequent lung lesions, less efficient feed conversion, lower offal quality, and poorer
meat quality grade (Cernicchiaro et al., 2012; Tennant et al., 2014). Health interventions in
arriving animals can reduce the risk of high levels of morbidity during the feeding period.
The hierarchical structure of cattle feedlot performance and cost data consists of cohorts
of cattle nested within feedlots. Random effects for feedlots and pen size can be used to model
animal performance determinants and account for clustering at the feedlot level and animal
management practices that differ across feedlots. The impact of other observable feedlot and
cattle characteristicssuch as breed, arrival weight, and health treatment practiceon animal
feeding performance is captured through fixed effects. For example, effects of morbidity
during feeding can be modeled by changes in animal productivity measures of average daily
gain, feed conversion, and veterinary costs. Multivariate Tobit, ordinary least squares, and
maximum likelihood have been used to model changes in average daily gain, veterinary costs,
and feed conversion in cattle (Miller et al., 2005; Irsik et al., 2006; Belasco, 2008; Belasco et
al., 2009).
Using the feedlot data, described in the main text, we quantify the impact of mortality on
γk in the simulation using linear mixed model (LMM) regressions, which are commonly used
in epidemiologic studies. Morbidity in cattle is not directly observed in the data but manifests
itself in lower ADG, increased AFC, and increased HC. Estimated regressions relating these
performance parameters to death loss are a combination of pen- and feedlot-specific fixed
effects and random effects from specific variables, including pen size, breed, specific feedlot,
year, placement weight, gender, and quarterly dummies. Specifically, we estimate cattle
performance parameters ADG and AFC using data from period 1 and associated health













































where ADG, AFC, and HC are as previously specified, MORT is the proportion of animals in
a pen that died during the feeding period, and lnPWT is the natural log of weight of cattle
upon arrival at feedlot. Higher placement weights are associated with lower daily gains and
higher feed conversion. STEER is a binary variable equal to 1 if group gender is a steer and 0
otherwise and SPRING, SUMMER, and FALL are quarterly binary variables for placement
on feed timing. Steers are associated with higher daily gains and lower feed conversions.
METAPHYLAXIS is a binary variable equal to 1 if an animal was part of a pen of cattle
administered antimicrobials upon arrival at the feeding operation and 0 otherwise. If meta-
phylaxis is used, a producer incurs an estimated $23.81/head, consistent with results from
the National Animal Health Monitoring Survey (NAHMS, U.S. Department of Agriculture,
2013) that reported costs of $23.50/head to administer metaphylaxis to at-risk feeder cattle.
In the simulation, MORT, lnPWT, and METAPHYLAXIS are varied, but we multiplied the
proportion of steers placed on feed over the past 10 years to obtain an average gender and
multiplied the seasonal coefficients by the proportion of cattle placed on feed over the last
10 years to obtain an average season. Thus, the simulation effects are for the average gender
over an average season.
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Retail beef, billion lb. (retail weight) 17.40
Wholesale beef, billion lb. (carcass weight) 23.78
Wholesale beef imports, billion lb. (carcass weight) 3.37
Wholesale beef exports, billion lb. (carcass weight) 2.27
Beef obtained from slaughter cattle, billion lb. (live weight) 39.11
Beef obtained from feeder cattle, billion lb. (live weight) 34.30
Pork
Retail pork, billion lb. (retail weight) 15.94
Wholesale pork, billion lb. (carcass weight) 24.50
Wholesale pork imports, billion lb. (carcass weight) 1.12
Wholesale pork exports, billion lb. (carcass weight) 5.01
Pork obtained from slaughter hogs, billion lb. (live weight) 32.68
Lamb
Retail domestic lamb, billion lb. (retail weight) 0.13
Retail imported lamb, billion lb. (retail weight) 0.19
Wholesale lamb, billion lb. (carcass weight) 0.15
Lamb obtained from slaughter lamb, billion lb. (live weight) 0.30
Lamb obtained from feeder lamb, billion lb. (live weight) 0.26
Poultry
Retail poultry, billion lb. (retail weight) 33.56
Wholesale poultry, billion lb. (ready-to-cook) 46.20
Retail poultry exports, billion lb. (retail weight) 6.99
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Choice retail beef, cents/lb. 628.89
Wholesale Choice beef, cents/lb. 237.48
Wholesale beef imports, cents/lb. 198.10
Wholesale beef exports, cents/lb. 237.48
Slaughter cattle, $/cwt (live weight) 148.12
Feeder cattle, $/cwt 202.92
Pork
Retail pork, cents/lb. 385.25
Wholesale pork, cents/lb. 78.96
Wholesale pork imports, cents/lb. 149.13
Wholesale pork exports, cents/lb. 78.96
Slaughter hogs, $/cwt (live weight) 50.23
Lamb
Retail domestic lamb, cents/lb. 769.61
Retail imported lamb, cents/lb. 955.67
Wholesale lamb, cents/lb. 346.70
Slaughter lamb, $/cwt (live weight) 144.00
Feeder lamb, $/cwt 192.38
Poultry
Retail poultry, cents/lb. 189.73
Wholesale poultry, cents/lb. 93.64





Table C.1: Financial Losses Due to Cattle Death Loss
Death Loss ($/head)
(head) 550 lbs. 700 lbs. 850 lbs.
0 0 0 0
1 997 1,117 1,250
2 1,993 2,233 2,500
3 2,990 3,350 3,750
4 3,987 4,466 5,000
5 4,984 5,583 6,250
6 5,980 6,699 7,500
7 6,977 7,816 8,750
8 7,974 8,933 10,000
9 8,970 10,049 11,250
10 9,967 11,166 12,500
11 10,964 12,282 13,750
12 11,961 13,399 15,000
13 12,957 14,515 16,250
14 13,954 15,632 17,500
15 14,951 16,749 18,750
16 15,947 17,865 20,000
17 16,944 18,982 21,250
18 17,941 20,098 22,500
19 18,937 21,215 23,750
20 19,934 22,331 25,000
21 20,931 23,448 26,250
22 21,928 24,565 27,500
23 22,924 25,681 28,750
24 23,921 26,798 30,000
25 24,918 27,914 31,250
26 25,914 29,031 32,500
27 26,911 30,147 33,750
28 27,908 31,264 35,000
29 28,905 32,381 36,250
30 29,901 33,497 37,500
Note: Assumes that all cattle
death occurs within the first day
on feed.Thus, feed, yardage, health,
and interest costs are negligible.
Feeder prices were taken using a five
year average for medium and large
frame #1 from combined Nebraska
auctions (LMIC 2019). Prices for
550 lb., 700 lb., and 850 lb. feeder
cattle are $1.8122, $1.5951, and
$1.4706 per lb., respectively.
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